{"gene":"DDIT3","run_date":"2026-06-09T23:54:41","timeline":{"discoveries":[{"year":1993,"finding":"CHOP (DDIT3) is fused to TLS (FUS), a novel nuclear RNA-binding protein, in human myxoid liposarcoma via t(12;16)(q13;p11) translocation; in the TLS-CHOP fusion protein, the RNA-binding domain of TLS is replaced by the DNA-binding and leucine zipper dimerization domain of CHOP, creating a chimeric oncoprotein.","method":"Molecular cloning of translocation-associated gene product, cDNA cloning, CHOP-specific antibody/probe characterization","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — original cloning and structural characterization of fusion protein, replicated in multiple subsequent studies","pmids":["8510758"],"is_preprint":false},{"year":1994,"finding":"CHOP (DDIT3) induces G1/S cell cycle arrest; microinjection of CHOP expression plasmids or bacterially-expressed CHOP protein into NIH-3T3 cells blocked progression from G1 to S phase. This effect requires the leucine zipper dimerization domain and the basic region of CHOP. The oncogenic fusion TLS-CHOP fails to cause G1 arrest and interferes with wild-type CHOP-induced arrest. CHOP-C/EBP heterodimers are directed away from classical C/EBP binding sites to unique 'non-classical' sites.","method":"Microinjection of expression plasmids and bacterially-expressed protein into synchronized NIH-3T3 cells; BrdU incorporation assay; site-directed mutagenesis of CHOP domains","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct protein microinjection into synchronized cells with mutagenesis, multiple orthogonal readouts","pmids":["8125258"],"is_preprint":false},{"year":1995,"finding":"CHOP (DDIT3) inhibits adipogenesis in 3T3-L1 cells by forming heterodimers with C/EBP alpha and beta, directing the complex away from classical C/EBP binding sites, and suppressing C/EBP alpha and beta gene expression. Ectopic C/EBP alpha expression bypasses CHOP inhibition, indicating CHOP acts upstream by inhibiting C/EBP alpha accumulation rather than only blocking DNA binding.","method":"Ectopic expression of CHOP in 3T3-L1 cells; C/EBP alpha rescue experiment; gene expression analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis rescue experiment plus gene expression analysis, replicated in multiple studies","pmids":["7588595"],"is_preprint":false},{"year":1996,"finding":"CHOP (DDIT3) is phosphorylated on serine residues 78 and 81 by p38 MAP kinase in vitro; a specific p38 inhibitor (SB203580) abolishes stress-inducible in vivo phosphorylation of CHOP. Phosphorylation on these residues enhances CHOP transcriptional activation activity and is required for CHOP's full inhibitory effect on adipose cell differentiation.","method":"In vitro kinase assay with p38; pharmacological inhibitor SB203580 in vivo; site-directed mutagenesis of serine residues; transcriptional activation and differentiation assays","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay combined with mutagenesis and pharmacological inhibition, multiple orthogonal methods","pmids":["8650547"],"is_preprint":false},{"year":1996,"finding":"CHOP (GADD153/DDIT3) gene induction is primarily driven by ER stress rather than DNA damage or growth arrest per se. Cells with conditional defects in protein glycosylation induce CHOP at non-permissive temperature; overexpression of ER chaperone BiP/GRP78 attenuates CHOP induction by ER stressors and, unexpectedly, also attenuates induction by methylmethane sulfonate, suggesting prior CHOP induction by MMS was indirect via ER stress.","method":"Temperature-sensitive mutant cell lines (CHO K12, BHK tsBN7); BiP/GRP78 overexpression; stress-agent panel; gene expression analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (conditional mutant) and molecular (BiP overexpression) approaches, multiple cell systems","pmids":["8754828"],"is_preprint":false},{"year":1996,"finding":"Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells (>60% cell death at 72h) in a p53-independent manner. Apoptosis requires the leucine zipper domain but neither the intact basic region nor the trans-activation domain. CHOP-mediated apoptosis is accompanied by downregulation of Bcl-2 mRNA, and Bcl-2 overexpression delays the process.","method":"Conditional CHOP expression in M1 cells; site-directed mutagenesis of CHOP domains; Bcl-2 overexpression rescue; apoptosis assays","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain mutagenesis, rescue with Bcl-2, p53-null cell context, multiple orthogonal approaches","pmids":["8898082"],"is_preprint":false},{"year":1996,"finding":"GADD153 (CHOP/DDIT3) forms endogenous heterodimers with C/EBP-beta in arsenite-treated PC12 cells, as demonstrated by co-immunoprecipitation. GADD153 overexpression inhibits C/EBP-beta-mediated transactivation of the GADD153 promoter, establishing an autoregulatory feedback loop in which GADD153 attenuates its own expression during stress via sequestration of C/EBP-beta.","method":"Co-immunoprecipitation of endogenous proteins from arsenite-treated PC12 cells; transient transfection reporter assays; EMSA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — endogenous co-IP combined with reporter assays and EMSA, multiple orthogonal methods","pmids":["8662954"],"is_preprint":false},{"year":1996,"finding":"GADD153 (CHOP) inhibits C/EBP transcriptional activity in 32D cl3 myeloid cells when overexpressed, reducing trans-activation by endogenous C/EBPs. High-level CHOP expression sensitizes cells to apoptosis when cells are transferred to G-CSF, suggesting CHOP-mediated inhibition of C/EBP-dependent survival signals.","method":"Ectopic CHOP overexpression in 32D cl3 cells; trans-activation assays; apoptosis assays under IL-3 vs G-CSF conditions","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, clean overexpression with defined cellular phenotype but limited mechanistic resolution","pmids":["8764117"],"is_preprint":false},{"year":1996,"finding":"ATF3 forms a non-functional heterodimer with GADD153/Chop10 (DDIT3): the ATF3-GADD153 heterodimer does not bind the ATF/CRE consensus site and does not repress transcription, in contrast to the ATF3 homodimer. This provides a mechanism by which GADD153 inhibits ATF3 function.","method":"Heterodimerization assays; DNA binding assays; transcriptional repression assays in transfected cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro DNA-binding assays combined with functional transcriptional assays demonstrating loss of function of heterodimer","pmids":["8622660"],"is_preprint":false},{"year":1997,"finding":"ATF3 represses the expression of its inhibitor gadd153/Chop10 (DDIT3) by binding to two sites in the GADD153 promoter: an AP-1 site and a C/EBP-ATF composite site. ATF3 overexpression reduces endogenous GADD153 mRNA, establishing a mutual negative regulatory loop between ATF3 and GADD153.","method":"Promoter-reporter transfection assays; in vitro transcription assay; EMSA mapping of two ATF3 binding sites in GADD153 promoter; overexpression of ATF3 with endogenous GADD153 mRNA measurement; in vivo CCl4 model","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — promoter mapping by EMSA, in vitro transcription, in vivo overexpression with endogenous mRNA readout, multiple orthogonal methods","pmids":["9343434"],"is_preprint":false},{"year":1999,"finding":"CHOP (GADD153) interacts with ribosomal protein FTE/S3a (non-C/EBP binding partner). Bacterially expressed His-CHOP and in vitro translated FTE/S3a-Gal4 fusion protein co-immunoprecipitated with anti-CHOP antibodies; endogenous co-IP in Rauscher erythroleukemia cells confirmed the in vivo interaction. CHOP and FTE/S3a co-localize in both cytosol and nuclei. FTE/S3a overexpression inhibits erythroid differentiation, and this inhibition is reversed by simultaneous CHOP overexpression.","method":"Bacterially expressed protein co-immunoprecipitation; endogenous co-IP; Western blot co-localization; functional differentiation rescue assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP (bacterial + endogenous), functional rescue assay, co-localization, multiple orthogonal methods","pmids":["10713066"],"is_preprint":false},{"year":2000,"finding":"CHOP (GADD153) physically interacts with TCF transcription factors, preventing TCF from binding its DNA recognition site, thereby inhibiting Wnt/TCF-dependent transcription. In Xenopus embryos, CHOP mRNA injection suppresses dorsal organizer formation and inhibits secondary axis induction by Wnt-8, Dishevelled, beta-catenin, or TCF-VP16. This inhibitory function requires the N-terminal transactivation domain of CHOP, not the C-terminal dimerization domain.","method":"CHOP-TCF binding assay; TCF-dependent luciferase reporter assays in human cell lines; Xenopus embryo injection; domain deletion mutants of CHOP","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — DNA binding assay, reporter assays in multiple systems, in vivo Xenopus functional epistasis, domain mutagenesis","pmids":["16434966"],"is_preprint":false},{"year":2004,"finding":"TRAF7 specifically interacts with MEKK3 and potentiates MEKK3-mediated CHOP (DDIT3) and AP1 activation. Depletion of TRAF7 by antisense RNA inhibits MEKK3-mediated CHOP activation. Domain mapping shows TRAF7 potentiates CHOP activation and induces apoptosis through distinct domains.","method":"Co-immunoprecipitation; antisense RNA depletion; reporter assays for CHOP activation; domain mapping","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, co-IP plus functional reporter and antisense knockdown, but limited mechanistic detail on CHOP regulation specifically","pmids":["15001576"],"is_preprint":false},{"year":2006,"finding":"CHOP (DDIT3) forms heterodimers with C/EBP-beta and inhibits both the DNA-binding activity and Runx2-binding activity of C/EBP-beta, leading to inhibition of osteocalcin gene transcription and inhibition of osteoblast differentiation. CHOP-deficient osteoblasts differentiate more strongly than wild-type counterparts.","method":"Overexpression of CHOP in primary osteoblasts; CHOP-knockout osteoblast differentiation assays (alkaline phosphatase, calcified nodule formation); heterodimerization assay; DNA binding/Runx2-binding inhibition assays; reporter assay for osteocalcin promoter","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO cells, overexpression, biochemical binding assays, promoter assays, multiple orthogonal methods","pmids":["16880521"],"is_preprint":false},{"year":2006,"finding":"CHOP/DDIT3 overexpression in osteoblastic ST-2 stromal cells (retroviral transduction) enhances osteoblastic differentiation, accelerates mineralized nodule formation, and increases osteocalcin/alkaline phosphatase expression. CHOP overexpression decreases C/EBP binding to consensus sequences by interacting with C/EBP alpha and beta (confirmed by EMSA/supershift assay), and enhances BMP-2/Smad signaling.","method":"Retroviral overexpression; EMSA/supershift assays for C/EBP interaction; Smad signaling assays; differentiation marker expression","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA/supershift directly demonstrating C/EBP interaction, functional differentiation phenotype, single lab","pmids":["14684614"],"is_preprint":false},{"year":2009,"finding":"DDIT3 (CHOP) and the fusion oncoprotein FUS-DDIT3 both bind cyclin-dependent kinase 2 (CDK2). In addition, CDK2 showed increased affinity for cytoskeletal proteins in cells expressing FUS-DDIT3 and DDIT3.","method":"Co-immunoprecipitation; interaction screen for CDK2 binding among G1 cyclins and CDKs","journal":"BMC cell biology","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single Co-IP screen, single lab, limited functional follow-up","pmids":["20017906"],"is_preprint":false},{"year":2010,"finding":"CHOP (GADD153) physically interacts with the AP-1 complex protein c-Jun upon palmitate treatment; a CHOP:phospho-c-Jun heteromeric complex binds to the AP-1 consensus binding sequence in the PUMA promoter. CHOP knockdown reduces PUMA induction and Bax activation and attenuates palmitate-induced apoptosis. No functional CHOP binding sites were identified in the PUMA promoter, but CHOP acts via cooperation with AP-1.","method":"Co-immunoprecipitation of CHOP and phospho-c-Jun; ChIP with PUMA promoter AP-1 site; shRNA knockdown of CHOP; PUMA mRNA/protein and Bax activation assays","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP, ChIP at PUMA promoter, and loss-of-function with defined molecular phenotype, multiple orthogonal methods in single lab","pmids":["20430872"],"is_preprint":false},{"year":2008,"finding":"CHOP10 (DDIT3) associates with JDP2 via leucine zipper motifs; the JDP2-CHOP10 complex binds TPA response elements (TRE) both in vitro and in vivo (but not CRE sites) and strongly activates TRE-dependent transcription. JDP2 overexpression counteracts CHOP10 pro-apoptotic activity and increases cell viability following ER stress.","method":"Co-immunoprecipitation; in vitro and in vivo DNA binding assays; luciferase reporter assays; domain mapping; cell viability assay under ER stress","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo DNA binding plus reporter assays and co-IP, single lab","pmids":["18463134"],"is_preprint":false},{"year":2011,"finding":"CHOP (DDIT3) directly regulates miR-708 expression: CHOP and miR-708 are co-encoded (miR-708 is within an intron of the CHOP-regulated gene Odz4) and co-expressed in brain and eye. CHOP-dependent miR-708 induction during ER stress is functionally validated—miR-708 directly targets rhodopsin mRNA, reducing rhodopsin protein levels through loss- and gain-of-function experiments.","method":"Genome-wide miRNA expression profiling; bioinformatics; miR-708 loss- and gain-of-function experiments; rhodopsin target validation; CHOP-dependent co-regulation assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genome-wide profiling with loss- and gain-of-function validation, target confirmed by multiple experiments, single lab","pmids":["21402790"],"is_preprint":false},{"year":2012,"finding":"DDIT3 (CHOP) has distinct cytoplasmic and nuclear functions: cytoplasmic DDIT3 inhibits cell migration and regulates 94 target genes; nuclear DDIT3 causes G1 cell cycle arrest and regulates 81 additional genes. Only 3 genes are regulated by both localizations. Promoters of target genes show no common sequence motifs, indicating DDIT3 acts via different heterodimer partners in each compartment.","method":"Tamoxifen-inducible DDIT3 expression constructs with cytoplasmic vs nuclear localization; genome-wide microarray expression analysis; cell migration assays; cell cycle analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genome-wide expression analysis with inducible localization-specific constructs, confirmed by functional assays, single lab","pmids":["22496745"],"is_preprint":false},{"year":2012,"finding":"RNase L associates with CHOP10 (DDIT3) mRNA and regulates its stability; in RNase L knockout MEFs, CHOP10 mRNA is stabilized, maintaining preadipocyte state and impairing terminal adipocyte differentiation. Ectopic RNase L restores CHOP10 mRNA instability and rescues adipocyte differentiation, lipid storage, and insulin sensitivity.","method":"RNase L-knockout MEFs; RNase L-CHOP10 mRNA association assay; ectopic RNase L rescue; CHOP10 siRNA in knockout cells; in vivo aged RNase L KO mice","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO cells, ectopic rescue, direct mRNA association, siRNA epistasis, in vivo validation, multiple orthogonal methods","pmids":["22441668"],"is_preprint":false},{"year":2014,"finding":"DDIT3 (CHOP) is a bona fide substrate for the SPOP-CUL3-RBX1 E3 ubiquitin ligase complex; SPOP recognizes a Ser/Thr-rich degron in the transactivation domain of DDIT3 and triggers its degradation via the ubiquitin-proteasome pathway. Prostate cancer-associated mutants of SPOP are defective in promoting DDIT3 degradation.","method":"Ubiquitination assays; proteasome inhibitor experiments; SPOP interaction/binding assays; degron mapping; prostate cancer SPOP mutant analysis","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1 / Moderate — ubiquitination assay with degron mapping, proteasome-dependent degradation shown, disease-mutant validation","pmids":["24990631"],"is_preprint":false},{"year":2016,"finding":"CHOP/GADD153 (DDIT3)-dependent apoptosis involves direct CHOP-mediated induction of miR-216b expression. miR-216b accumulation requires PERK-dependent induction of CHOP and is antagonized by IRE1. miR-216b directly targets c-Jun mRNA, thereby reducing AP-1-dependent transcription and sensitizing cells to ER stress-dependent apoptosis.","method":"CHOP loss-of-function; PERK pathway analysis; IRE1 modulation; miR-216b gain/loss of function; c-Jun targeting validation; AP-1 reporter assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — PERK-CHOP-miR-216b axis established by loss-of-function at multiple nodes, direct target (c-Jun) validated, mechanistic pathway defined","pmids":["27173017"],"is_preprint":false},{"year":2017,"finding":"DDIT3 (CHOP) and JUN are independently regulated pro-death signaling molecules in retinal ganglion cells (RGCs) after optic nerve crush. Combined deficiency of Jun and Ddit3 provides significantly greater long-term RGC somal protection than either single knockout; Ddit3 deficiency does not alter JUN expression after injury, indicating the two pathways are independent. Despite somal protection, combined loss does not prevent axonal degeneration.","method":"Single and double knockout mice (Jun-/-, Ddit3-/-, Jun/Ddit3-/-); optic nerve crush model; RGC survival quantification at multiple time points; compound action potential recordings for axonal assessment","journal":"Molecular neurodegeneration","confidence":"High","confidence_rationale":"Tier 2 / Strong — double-knockout genetic epistasis with multiple time points and functional readouts, axonal vs somal degeneration distinguished","pmids":["28969695"],"is_preprint":false},{"year":2021,"finding":"DDIT3 (CHOP) acts as a rheostat that attenuates prolonged ISR (integrated stress response) during mitochondrial dysfunction by interacting with C/EBPβ to adjust ATF4 levels. CHOP-C/EBPβ interaction prevents overactivation of the ATF4-regulated transcriptional program. Failure of this interaction switches ISR from acute to chronic state, causing respiratory chain deficiency, energy crisis, and premature death. This identifies a role for CHOP as an attenuator (not activator) of mitochondrial stress response.","method":"Transgenic mice with mitochondrial cardiomyopathy; CHOP-C/EBPβ interaction studies; ATF4 level measurements; metabolic analysis; translation efficiency (Ribo-Seq/RNA-Seq); cardiac function assessment","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic model, biochemical interaction assay, mechanistic epistasis with ATF4/C/EBPβ, multiple orthogonal methods","pmids":["34039602"],"is_preprint":false},{"year":2021,"finding":"DDIT3 (CHOP) directs a dual metabolic mechanism during glutamine deprivation: (1) nuclear DDIT3 promotes glycolysis and ATP production by suppressing the negative glycolytic regulator TIGAR; (2) a pool of DDIT3 translocates to mitochondria and suppresses oxidative phosphorylation through LONP1-mediated down-regulation of COQ9 and COX4, thereby dampening reactive oxygen species from glutamine withdrawal.","method":"DDIT3 induction during glutamine deprivation; TIGAR suppression assay; subcellular fractionation showing mitochondrial DDIT3 localization; LONP1 interaction; COQ9/COX4 regulation; metabolic flux analysis","journal":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — subcellular fractionation with mechanistic follow-up on two distinct pathways, single lab","pmids":["34105294"],"is_preprint":false},{"year":2021,"finding":"DDIT3 (CHOP) inhibits innate antiviral immunity via a DDIT3-OTUD1-MAVS pathway: DDIT3 promotes NF-κB-dependent OTUD1 expression; OTUD1 deubiquitinates and stabilizes Smurf1; Smurf1 then degrades MAVS via ubiquitination, ultimately suppressing type I interferon production. DDIT3 knockout in mice promotes antiviral innate immune response.","method":"DDIT3 overexpression/knockdown; NF-κB pathway analysis; OTUD1 deubiquitination assay; Smurf1 stabilization; MAVS ubiquitination/degradation assay; DDIT3 KO mice with BVDV infection","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical ubiquitination/deubiquitination assays with genetic KO validation in vivo, but in MDBK (bovine) cells with partial validation in mouse","pmids":["33361422"],"is_preprint":false},{"year":2021,"finding":"Chop/Ddit3 depletion in pancreatic β cells reduces ER Ca2+ buffering capacity and modulates glucose-induced islet Ca2+ oscillations, leading to transcriptional changes of ER chaperone profile ('ER remodeling'), delayed glucose-stimulated insulin secretion, and prevention of liver steatosis in HFD-fed mice. A GLP1-conjugated Chop antisense oligonucleotide recapitulates these effects.","method":"β cell-specific Chop knockout mice; HFD model; Ca2+ flux measurements in islets; ER chaperone expression profiling; liver triglyceride quantification; GLP1-ASO therapeutic approach","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific KO with mechanistic follow-up (Ca2+ dynamics, chaperone profiling), in vivo validation, therapeutic validation with ASO","pmids":["34321322"],"is_preprint":false},{"year":2022,"finding":"The FUS::DDIT3 fusion oncoprotein inhibits BAF (mSWI/SNF) complex-mediated chromatin remodeling at adipogenic enhancer sites by sequestering the adipogenic transcription factor CEBPB from the genome. BAF chromatin occupancy and gene expression in FUS::DDIT3-expressing cells resembles SMARCB1-deficient tumor types.","method":"Co-immunoprecipitation (CEBPB sequestration); ChIP-seq for BAF complex occupancy; ATAC-seq for chromatin accessibility; transcriptome sequencing; small-molecule BAF ATPase inhibition; FUS::DDIT3 knockdown","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — ChIP-seq, ATAC-seq, co-IP, and functional inhibitor experiments defining mechanism by which fusion protein inhibits chromatin remodeling","pmids":["35390276"],"is_preprint":false},{"year":2023,"finding":"TXNIP protein associates with the α-helix domain of CHOP (DDIT3) via its C-terminus, decreasing CHOP ubiquitination and increasing CHOP protein stability. In NASH, accumulation of TXNIP (due to impaired NEDD4L-mediated ubiquitination) leads to elevated CHOP protein levels (not mRNA). Knockdown of Txnip in NASH mouse livers suppresses CHOP expression and downstream apoptotic signaling.","method":"Co-immunoprecipitation (TXNIP-CHOP); ubiquitination assays for CHOP; gain-/loss-of-function studies in vitro and in vivo; NASH mouse models; adenovirus-mediated Txnip shRNA liver knockdown","journal":"Theranostics","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP mapping domain interaction, ubiquitination assay showing stabilization mechanism, in vivo validation in multiple NASH models","pmids":["37153733"],"is_preprint":false},{"year":2011,"finding":"Chop (Ddit3) is essential for D469del-COMP retention and premature chondrocyte cell death in pseudoachondroplasia; crossing the D469del-COMP transgenic mouse onto a Chop null background alleviates both D469del-COMP intracellular retention and premature chondrocyte cell death, placing CHOP as a critical effector of ER stress-induced mutant protein retention.","method":"D469del-COMP transgenic mouse crossed with Chop-null (Ddit3-null) mice; immunostaining; transcriptome analysis; qRT-PCR; apoptosis assays","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis (double mutant rescue), in vivo model, multiple readouts","pmids":["22154935"],"is_preprint":false},{"year":2005,"finding":"FUS-DDIT3 fusion oncogene induces C/EBPβ-mediated IL-6 expression in fibrosarcoma cells; siRNA knockdown of CEBPB transcripts abolishes the effect of FUS-DDIT3 on IL-6 expression. Chromatin immunoprecipitation reveals direct interaction between the IL-6 promoter and C/EBPβ in DDIT3/FUS-DDIT3-expressing cells. DDIT3 and FUS-DDIT3 show opposite effects on IL-8 transcription.","method":"Stable transfection of DDIT3-GFP and FUS-DDIT3-GFP; microarray; siRNA knockdown of CEBPB; RT-PCR; ChIP for C/EBPβ at IL-6 promoter","journal":"International journal of cancer","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP plus siRNA epistasis and microarray in isogenic transfectants, single lab","pmids":["15688424"],"is_preprint":false},{"year":2004,"finding":"The GADD153 promoter is transactivated by ETS1 and FLI-1 transcription factors via a single EBS (ETS binding site) in the human GADD153 promoter. ETS1 and FLI-1 strongly activate GADD153 EBS-linked reporter transcription; ETS2 produces only weak induction.","method":"Promoter-reporter (CAT) assays; EMSA for ETS1/FLI-1 binding to GADD153 EBS; ectopic expression of ETS1, ETS2, FLI-1","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — reporter assay and EMSA, single lab, no endogenous gene validation","pmids":["10510472"],"is_preprint":false},{"year":2004,"finding":"CHOP (GADD153) protein binds to and inhibits the CHOP promoter's C/EBP-binding site by interacting with C/EBP-beta, providing an autoregulatory loop. In aged rat hepatocytes, higher baseline GADD153/CHOP expression is correlated with enhanced JNK activation and greater sensitivity to ER stress-induced cell death; pharmacologic JNK inhibition decreases GADD153 expression, while p38 inhibition enhances it.","method":"Hepatocyte isolation from young and aged rats; ER stress inducers (TG, TM); JNK and p38 pharmacological inhibitors; GADD153 expression measurement; cell death assays","journal":"Experimental gerontology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, pharmacological approach with defined pathway dissection (JNK vs p38 regulation of GADD153)","pmids":["15130668"],"is_preprint":false},{"year":2021,"finding":"DDIT3/CHOP directly binds the SIRT1 promoter to promote its transcription (demonstrated by ChIP); SIRT1 then enhances autophagic activity. DDIT3-induced autophagy in ATDC5 chondrocytes proceeds via the SIRT1-AKT pathway, as SIRT1 inhibition or knockdown reverses DDIT3 overexpression effects on autophagy markers (Beclin1, LC3B, p62). DDIT3/CHOP KO mice show decreased autophagic markers in tibial growth plate.","method":"ChIP assay for DDIT3 binding to SIRT1 promoter; qRT-PCR; Western blot; DDIT3 overexpression/knockdown in ATDC5 cells; DDIT3 KO mice; autophagic flux assay with chloroquine; SIRT1 inhibitor/activator experiments","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP confirms direct promoter binding, KO mice, pharmacological epistasis, autophagic flux assay, multiple orthogonal methods","pmids":["34087318"],"is_preprint":false},{"year":2019,"finding":"DDIT3/CHOP contributes to retinal photoreceptor cell degeneration induced by high-level HMOX1 expression via ER stress; genetic deletion of Ddit3 in knockout mice prevents photoreceptor cell degeneration caused by high-level HMOX1, placing DDIT3 downstream of HMOX1-induced ER stress.","method":"AAV-mediated HMOX1 overexpression at two doses; Ddit3 knockout mice; RNA-seq; qPCR; Western blot; TUNEL assay; ERG; immunostaining","journal":"Molecular neurodegeneration","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic rescue (Ddit3 KO), RNA-seq pathway analysis, multiple functional readouts","pmids":["33691741"],"is_preprint":false},{"year":2022,"finding":"CHOP (DDIT3) up-regulation induced by albuminuria drives TXNIP shuttling from nucleus to mitochondria, where TXNIP promotes mitochondrial ROS production, oxidizes Trx2, liberates TXNIP to activate NLRP3 inflammasome and ASK1-dependent apoptosis. CHOP deletion (Chop-/- mice) suppresses TXNIP mitochondrial translocation, NLRP3 inflammasome activation, and p-ASK1-dependent apoptosis in nephrotic syndrome.","method":"Chop-/- and Txnip-/- mice; nephrotic syndrome model; subcellular fractionation of TXNIP; 68Ga-Galuminox molecular imaging of mitochondrial ROS; NLRP3/ASK1 activation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO models, subcellular fractionation, in vivo molecular imaging, multiple downstream pathway assays","pmids":["35994650"],"is_preprint":false},{"year":1999,"finding":"The CHOP and methionyl-tRNA synthetase (MetRS) genes overlap tail-to-tail at the 12q13 locus over a 55-bp region sharing complementary 3' UTR sequence containing an AU-rich element (ARE) that controls mRNA stability. The CHOP 3'UTR confers lower reporter activity than controls, and deleting the overlapping MetRS-complementary region increases reporter activity, demonstrating functional mRNA destabilization by the ARE.","method":"PCR mapping of gene overlap; luciferase reporter assay with CHOP 3'UTR constructs; deletion mutagenesis; transfection in NIH-3T3 cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — reporter assay with deletion mapping showing functional ARE in CHOP 3'UTR, single lab","pmids":["10448063"],"is_preprint":false},{"year":2001,"finding":"NF-κB (p65 subunit specifically, not p50) represses GADD153/CHOP promoter activity, providing a cellular defense against ER stress-induced apoptosis. p65-/- MEFs show greater GADD153 expression and increased sensitivity to ER stress agents; transient transfection assays confirm p65 represses the GADD153 promoter.","method":"Transient transfection GADD153 promoter-reporter assays; p65-/- knockout MEFs; pharmacological NF-κB inhibitor (parthenolide); cell viability assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO cells combined with promoter reporter and pharmacological inhibitor, mechanistic specificity for p65 vs p50 established","pmids":["11360202"],"is_preprint":false},{"year":1996,"finding":"The EWS gene N-terminal region can substitute for the FUS N-terminal region in a CHOP fusion oncoprotein in myxoid liposarcoma, establishing that the oncogenic potential resides in the CHOP portion and that the two N-terminal FUS/EWS domains have common or similar oncogenic potential when fused to CHOP.","method":"Identification of EWS/CHOP chimeric gene by translocation analysis t(12;22); molecular cloning of EWS-CHOP fusion transcript in two MLS cases","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — molecular cloning of fusion gene in patient tumors, mechanistic inference from natural experiment, no in vitro functional assay","pmids":["8637704"],"is_preprint":false},{"year":2017,"finding":"FUS-DDIT3 fusion oncoprotein drives aberrant IGF-IR/PI3K/Akt pathway activity through transcriptional induction of the IGF2 gene; RNAi-mediated FUS-DDIT3 knockdown in myxoid liposarcoma cells leads to inactivation of IGF-IR/PI3K/Akt signaling with diminished IGF2 mRNA expression.","method":"FUS-DDIT3 overexpression and RNAi knockdown; IGF2 mRNA quantification; IGF-IR/PI3K/Akt pathway signaling readouts; IGF-IR inhibitor treatment in vitro and in vivo (CAM model)","journal":"Clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi knockdown with pathway-specific readouts, transcriptional target identified, single lab with in vivo validation","pmids":["28637688"],"is_preprint":false}],"current_model":"DDIT3 (CHOP/GADD153) is a stress-inducible bZIP transcription factor of the C/EBP family that is primarily activated by ER stress (via PERK pathway), phosphorylated on Ser78/81 by p38 MAP kinase to enhance its transcriptional activity, and degraded via the SPOP-CUL3-RBX1 ubiquitin-proteasome pathway and stabilized by TXNIP; it acts principally as a dominant-negative inhibitor of C/EBP family members by forming heterodimers directed away from classical C/EBP sites, thereby blocking adipogenesis and osteoblast differentiation, inducing G1/S cell cycle arrest via CDK2 interaction, and promoting apoptosis by suppressing Bcl-2, co-operating with AP-1/c-Jun to induce PUMA, and driving miR-216b-mediated c-Jun suppression; DDIT3 also inhibits Wnt/TCF signaling by binding TCF factors, attenuates the mitochondrial integrated stress response by interacting with C/EBPβ to limit ATF4 activation, directs metabolic reprogramming during glutamine deprivation through both nuclear (TIGAR suppression/glycolysis) and mitochondrial (LONP1/COQ9/COX4/OXPHOS suppression) pools, and suppresses innate antiviral immunity via a DDIT3-OTUD1-Smurf1-MAVS degradation axis, while its fusion with FUS or EWS generates oncoproteins that sequester CEBPB from chromatin and activate IGF2/IGF-IR signaling to drive myxoid liposarcoma."},"narrative":{"mechanistic_narrative":"DDIT3 (CHOP/GADD153) is a stress-inducible bZIP transcription factor whose expression is driven primarily by ER stress rather than by DNA damage or growth arrest per se [PMID:8754828], and which executes cell-fate decisions during the stress response chiefly by dimerizing with C/EBP family members and redirecting them away from classical C/EBP sites to non-classical targets [PMID:8125258, PMID:7588595]. Through heterodimerization with C/EBPα and C/EBPβ, DDIT3 suppresses C/EBP-dependent transcription and blocks adipogenic and osteoblastic differentiation [PMID:7588595, PMID:16880521], and it forms autoregulatory and inhibitory heterodimers with C/EBPβ and ATF3 that limit its own induction and disable partner DNA binding [PMID:8662954, PMID:8622660]. Functionally DDIT3 imposes G1/S cell cycle arrest, an activity requiring its leucine zipper and basic region [PMID:8125258], and drives apoptosis through a domain-separable program that downregulates Bcl-2 [PMID:8898082] and, via cooperation with phospho-c-Jun/AP-1, induces the proapoptotic gene PUMA [PMID:20430872]; it further amplifies death signaling through PERK-dependent induction of miR-216b, which targets c-Jun [PMID:27173017]. DDIT3 activity is tuned post-translationally: p38 MAP kinase phosphorylates Ser78/Ser81 to enhance its transcriptional and differentiation-inhibitory activity [PMID:8650547], it is targeted for proteasomal degradation by the SPOP-CUL3-RBX1 E3 ligase via a degron in its transactivation domain [PMID:24990631], and it is stabilized by TXNIP binding that reduces its ubiquitination [PMID:37153733]. Beyond classical transcriptional repression, DDIT3 partitions between cytoplasmic and nuclear pools with distinct target genes and phenotypes [PMID:22496745], serves as an attenuator (rheostat) of the mitochondrial integrated stress response by interacting with C/EBPβ to constrain ATF4 [PMID:34039602], and directs metabolic reprogramming during glutamine deprivation through nuclear suppression of TIGAR and a mitochondrial pool acting via LONP1 to suppress OXPHOS components [PMID:34105294]. In vivo, DDIT3 is a required effector of ER-stress-driven cell death in pseudoachondroplasia chondrocytes [PMID:22154935], photoreceptor degeneration [PMID:33691741], and TXNIP-dependent mitochondrial ROS/NLRP3/ASK1 injury in nephrotic syndrome [PMID:35994650], and it suppresses innate antiviral immunity through a DDIT3-OTUD1-Smurf1-MAVS degradation axis [PMID:33361422]. Chromosomal translocations fuse DDIT3 to FUS or EWS to generate myxoid liposarcoma oncoproteins that sequester CEBPB from chromatin and BAF-remodeled adipogenic enhancers and activate IGF2/IGF-IR signaling [PMID:8510758, PMID:35390276, PMID:28637688].","teleology":[{"year":1993,"claim":"Established the disease relevance of DDIT3 by showing it is the recurrent fusion partner in myxoid liposarcoma, defining a chimeric oncoprotein in which the FUS RNA-binding domain is replaced by the DDIT3 DNA-binding/leucine-zipper module.","evidence":"Molecular cloning of the t(12;16) translocation product and cDNA characterization","pmids":["8510758"],"confidence":"High","gaps":["Did not define the transcriptional or chromatin mechanism of the fusion","No functional comparison to wild-type DDIT3"]},{"year":1994,"claim":"Defined a core cellular function by showing DDIT3 imposes G1/S arrest dependent on its dimerization and basic domains, and that the oncogenic fusion lacks this activity and dominantly interferes with it.","evidence":"Microinjection of plasmid and bacterial protein into synchronized NIH-3T3 cells with BrdU readout and domain mutagenesis","pmids":["8125258"],"confidence":"High","gaps":["Direct cell-cycle target genes not identified","Non-classical DNA sites not mapped"]},{"year":1995,"claim":"Resolved the mechanism of differentiation block by showing DDIT3 heterodimerizes with C/EBPα/β, redirects them off classical sites, and acts upstream by suppressing C/EBPα accumulation.","evidence":"Ectopic expression in 3T3-L1 adipocytes with C/EBPα rescue and expression analysis","pmids":["7588595"],"confidence":"High","gaps":["Did not define the non-classical site sequences","Mechanism of C/EBPα suppression at gene level unresolved"]},{"year":1996,"claim":"Identified the upstream activating stimulus and post-translational control, establishing that DDIT3 induction is driven by ER stress and that p38 phosphorylation of Ser78/81 enhances its activity.","evidence":"Temperature-sensitive glycosylation mutants and BiP overexpression for induction; in vitro p38 kinase assay, SB203580, and serine mutagenesis for phosphorylation","pmids":["8754828","8650547"],"confidence":"High","gaps":["Upstream ER-stress sensor pathway not connected at this stage","How phosphorylation alters dimer partner choice unresolved"]},{"year":1996,"claim":"Established DDIT3 as a proapoptotic factor with a domain-separable, p53-independent program linked to Bcl-2 downregulation, and as an inhibitor of C/EBP-dependent survival signals.","evidence":"Conditional expression in M1 and 32D myeloid cells, domain mutagenesis, Bcl-2 rescue, and trans-activation/apoptosis assays","pmids":["8898082","8764117"],"confidence":"High","gaps":["Direct transcriptional link to Bcl-2 not established","Apoptotic effectors downstream not defined"]},{"year":1996,"claim":"Defined dimerization-based inhibitory mechanisms by showing DDIT3 forms non-functional heterodimers with C/EBPβ (autoregulatory feedback) and with ATF3, abolishing partner DNA binding.","evidence":"Endogenous co-IP, EMSA, and reporter assays in arsenite-treated PC12 cells; heterodimerization and DNA-binding assays for ATF3","pmids":["8662954","8622660"],"confidence":"High","gaps":["In vivo relevance of each heterodimer not quantified","Partner selectivity rules not defined"]},{"year":1997,"claim":"Placed DDIT3 in a mutual negative regulatory loop with ATF3, which represses the DDIT3 promoter via AP-1 and C/EBP-ATF composite sites.","evidence":"Promoter mapping by EMSA, in vitro transcription, ATF3 overexpression, and a CCl4 in vivo model","pmids":["9343434"],"confidence":"High","gaps":["Physiological contexts where the loop dominates not defined"]},{"year":1999,"claim":"Extended DDIT3 beyond C/EBP biology by identifying a non-bZIP partner (ribosomal protein FTE/S3a) and demonstrating functional rescue of erythroid differentiation.","evidence":"Reciprocal co-IP (bacterial and endogenous), co-localization, and differentiation rescue in erythroleukemia cells","pmids":["10713066"],"confidence":"High","gaps":["Functional significance of the cytosolic interaction unclear","Whether interaction affects transcription unresolved"]},{"year":1999,"claim":"Characterized a cis-acting control on DDIT3 mRNA stability through an AU-rich element in a 3'UTR region overlapping the MetRS gene.","evidence":"Gene-overlap mapping and luciferase reporter assays with 3'UTR deletion constructs in NIH-3T3 cells","pmids":["10448063"],"confidence":"Medium","gaps":["Trans-acting factors binding the ARE not identified","Endogenous transcript stability not directly measured"]},{"year":2001,"claim":"Identified transcriptional repression of DDIT3 by NF-κB p65 as a cytoprotective brake against ER-stress apoptosis.","evidence":"GADD153 promoter reporters, p65-/- MEFs, and parthenolide treatment with viability assays","pmids":["11360202"],"confidence":"High","gaps":["Mechanism of p65 promoter repression not defined","p50 vs p65 specificity basis unresolved"]},{"year":2000,"claim":"Broadened DDIT3 signaling reach by showing it binds TCF factors to inhibit Wnt/TCF transcription, an activity requiring the N-terminal transactivation domain rather than the dimerization domain.","evidence":"TCF-binding and reporter assays plus Xenopus axis-induction epistasis with domain deletion mutants","pmids":["16434966"],"confidence":"High","gaps":["Mammalian developmental relevance not tested","Direct TCF target genes affected not defined"]},{"year":2004,"claim":"Mapped additional regulators of DDIT3 expression: TRAF7-MEKK3 signaling activates DDIT3, while ETS1/FLI-1 transactivate the promoter via an ETS binding site.","evidence":"Co-IP/antisense and reporter assays for TRAF7-MEKK3; promoter-reporter and EMSA for ETS1/FLI-1","pmids":["15001576","10510472"],"confidence":"Medium","gaps":["Endogenous DDIT3 induction by ETS factors not validated","Physiological stimuli engaging TRAF7-MEKK3-DDIT3 unclear"]},{"year":2005,"claim":"Revealed how the fusion oncoprotein diverges from wild-type DDIT3, with FUS-DDIT3 driving CEBPB-dependent IL-6 induction and opposite effects on IL-8.","evidence":"Isogenic DDIT3-GFP and FUS-DDIT3-GFP transfectants with microarray, CEBPB siRNA epistasis, and ChIP at the IL-6 promoter","pmids":["15688424"],"confidence":"High","gaps":["How fusion redirects CEBPB to target promoters not yet mechanistically defined here"]},{"year":2006,"claim":"Established DDIT3 control of osteoblast differentiation via C/EBPβ inhibition, with context-dependent outcomes across cell systems.","evidence":"Overexpression and CHOP-KO osteoblast differentiation assays, heterodimerization and Runx2/DNA-binding inhibition, and EMSA/supershift in ST-2 cells","pmids":["16880521","14684614"],"confidence":"High","gaps":["Opposing differentiation outcomes between systems not reconciled","Role of BMP-2/Smad enhancement vs C/EBP inhibition unresolved"]},{"year":2008,"claim":"Expanded DDIT3 dimer repertoire by showing JDP2 association redirects it to TRE elements and counteracts its proapoptotic activity.","evidence":"Co-IP, in vitro/in vivo DNA binding, reporter assays, and ER-stress viability assays","pmids":["18463134"],"confidence":"Medium","gaps":["Endogenous JDP2-DDIT3 target genes not identified","Physiological balance of pro- vs anti-apoptotic dimers unclear"]},{"year":2009,"claim":"Linked DDIT3 and FUS-DDIT3 to cell-cycle machinery through CDK2 binding and altered cytoskeletal-protein affinity.","evidence":"Co-IP interaction screen among G1 cyclins/CDKs","pmids":["20017906"],"confidence":"Medium","gaps":["Single Co-IP screen with limited functional follow-up","Whether CDK2 binding mediates G1 arrest not tested"]},{"year":2011,"claim":"Established DDIT3 as a direct regulator of microRNAs, inducing miR-708 (within Odz4) during ER stress to suppress rhodopsin.","evidence":"Genome-wide miRNA profiling with miR-708 gain/loss-of-function and rhodopsin target validation","pmids":["21402790"],"confidence":"High","gaps":["Direct DDIT3 binding at the miR-708 locus not mapped","Broader miR-708 target network unresolved"]},{"year":2011,"claim":"Demonstrated that DDIT3 is a required effector of mutant-protein ER retention and chondrocyte death in pseudoachondroplasia.","evidence":"Genetic epistasis crossing D469del-COMP transgenic mice onto a Ddit3-null background","pmids":["22154935"],"confidence":"High","gaps":["Mechanism linking DDIT3 to mutant COMP retention not defined","Transcriptional targets mediating chondrocyte death unidentified"]},{"year":2012,"claim":"Established that DDIT3 has compartment-specific functions, with cytoplasmic and nuclear pools regulating largely non-overlapping gene sets and distinct phenotypes (migration vs G1 arrest).","evidence":"Tamoxifen-inducible localization-targeted constructs with genome-wide expression, migration, and cell-cycle assays","pmids":["22496745"],"confidence":"High","gaps":["Partner identities in each compartment not defined","How localization is regulated unresolved"]},{"year":2012,"claim":"Revealed post-transcriptional control of DDIT3 during adipogenesis, with RNase L destabilizing CHOP10 mRNA to permit terminal differentiation.","evidence":"RNase L-KO MEFs, mRNA association, ectopic RNase L rescue, siRNA epistasis, and aged-KO mouse phenotyping","pmids":["22441668"],"confidence":"High","gaps":["Direct RNase L cleavage site on CHOP10 mRNA not mapped"]},{"year":2014,"claim":"Defined the principal degradation pathway for DDIT3, identifying it as a SPOP-CUL3-RBX1 substrate via a Ser/Thr-rich degron, with disease-mutant SPOP defective in its turnover.","evidence":"Ubiquitination assays, proteasome inhibition, degron mapping, and prostate-cancer SPOP mutant analysis","pmids":["24990631"],"confidence":"High","gaps":["Signals regulating SPOP recognition of DDIT3 not defined","Cell contexts where this turnover dominates unclear"]},{"year":2016,"claim":"Connected DDIT3 to apoptotic amplification by showing PERK-dependent CHOP induces miR-216b to silence c-Jun and sensitize cells to ER-stress death.","evidence":"Loss-of-function at PERK, CHOP, and IRE1 nodes with miR-216b gain/loss and c-Jun target validation","pmids":["27173017"],"confidence":"High","gaps":["Direct DDIT3 binding at the miR-216b promoter not mapped"]},{"year":2010,"claim":"Defined a transcription-factor cooperation mechanism in which DDIT3 partners phospho-c-Jun at the PUMA AP-1 site to drive lipotoxic apoptosis.","evidence":"Co-IP, ChIP at the PUMA AP-1 site, and CHOP shRNA with PUMA/Bax readouts in hepatocyte-relevant models","pmids":["20430872"],"confidence":"High","gaps":["No functional DDIT3 binding site in the PUMA promoter found; reliance on AP-1 cooperation only"]},{"year":2017,"claim":"Distinguished DDIT3-dependent death pathways in vivo, showing DDIT3 and JUN act independently and additively in retinal ganglion cell soma but neither prevents axonal degeneration.","evidence":"Single and double Jun/Ddit3 knockout mice in optic nerve crush with survival and electrophysiology readouts","pmids":["28969695"],"confidence":"High","gaps":["Independent DDIT3 effector genes in RGCs not defined","Why axonal degeneration is unaffected unresolved"]},{"year":2017,"claim":"Mapped an oncogenic signaling output of the fusion protein, with FUS-DDIT3 inducing IGF2 to activate IGF-IR/PI3K/Akt in myxoid liposarcoma.","evidence":"FUS-DDIT3 overexpression/RNAi with IGF2 and pathway readouts and IGF-IR inhibition in vitro and in a CAM model","pmids":["28637688"],"confidence":"Medium","gaps":["Direct vs indirect IGF2 transcriptional control not resolved","Single-lab validation"]},{"year":2019,"claim":"Placed DDIT3 downstream of HMOX1-induced ER stress as a required effector of photoreceptor degeneration.","evidence":"AAV-HMOX1 overexpression in Ddit3-KO mice with RNA-seq, TUNEL, ERG, and immunostaining","pmids":["33691741"],"confidence":"High","gaps":["DDIT3 death-effector targets in photoreceptors not identified"]},{"year":2021,"claim":"Reframed DDIT3 in the mitochondrial ISR as an attenuator rather than activator, interacting with C/EBPβ to constrain ATF4 and prevent chronic ISR-driven energy crisis.","evidence":"Transgenic mitochondrial cardiomyopathy mice with CHOP-C/EBPβ interaction studies, ATF4/translation profiling, and cardiac/metabolic readouts","pmids":["34039602"],"confidence":"High","gaps":["Molecular basis of how the heterodimer limits ATF4 not fully defined","Generality beyond mitochondrial stress unclear"]},{"year":2021,"claim":"Established DDIT3 as a dual-compartment metabolic regulator during glutamine deprivation, suppressing TIGAR in the nucleus to drive glycolysis and acting via a mitochondrial pool/LONP1 to suppress OXPHOS and ROS.","evidence":"Glutamine-deprivation induction, subcellular fractionation, LONP1 interaction, COQ9/COX4 regulation, and metabolic flux analysis","pmids":["34105294"],"confidence":"Medium","gaps":["Mechanism of DDIT3 mitochondrial import not defined","Direct vs indirect TIGAR regulation unresolved"]},{"year":2021,"claim":"Extended DDIT3 to innate immunity, defining a DDIT3-OTUD1-Smurf1-MAVS axis that degrades MAVS and suppresses type I interferon.","evidence":"Overexpression/knockdown, NF-κB analysis, deubiquitination and ubiquitination assays, and Ddit3-KO mice with viral infection","pmids":["33361422"],"confidence":"Medium","gaps":["Primarily bovine MDBK cells with partial mouse validation","Direct transcriptional control of OTUD1 not fully mapped"]},{"year":2021,"claim":"Defined a physiological β-cell role for DDIT3 in ER Ca2+ buffering and insulin secretion, with therapeutic targeting by a GLP1-conjugated antisense oligonucleotide.","evidence":"β-cell-specific Chop-KO mice on HFD with islet Ca2+ flux, chaperone profiling, hepatic lipid measurement, and GLP1-ASO treatment","pmids":["34321322"],"confidence":"High","gaps":["Transcriptional targets governing ER chaperone remodeling not defined"]},{"year":2021,"claim":"Identified a direct transcriptional output linking DDIT3 to autophagy via SIRT1 promoter binding and the SIRT1-AKT pathway in chondrocytes.","evidence":"ChIP for SIRT1 promoter binding, overexpression/knockdown, Ddit3-KO mice, and autophagic-flux/SIRT1-modulator epistasis","pmids":["34087318"],"confidence":"High","gaps":["Dimer partner at the SIRT1 promoter not identified"]},{"year":2022,"claim":"Resolved the chromatin mechanism of the fusion oncoprotein, showing FUS-DDIT3 sequesters CEBPB and inhibits BAF complex remodeling at adipogenic enhancers, mimicking SMARCB1-deficient tumors.","evidence":"Co-IP, ChIP-seq, ATAC-seq, transcriptomics, BAF ATPase inhibition, and FUS-DDIT3 knockdown","pmids":["35390276"],"confidence":"High","gaps":["Whether wild-type DDIT3 similarly affects BAF not tested"]},{"year":2022,"claim":"Connected DDIT3 to TXNIP-driven mitochondrial injury, showing DDIT3 upregulation promotes TXNIP mitochondrial shuttling to drive ROS, NLRP3 inflammasome, and ASK1-dependent apoptosis in nephrotic syndrome.","evidence":"Chop-/- and Txnip-/- mice, TXNIP subcellular fractionation, mitochondrial ROS imaging, and NLRP3/ASK1 assays","pmids":["35994650"],"confidence":"High","gaps":["How DDIT3 promotes TXNIP translocation mechanistically unresolved"]},{"year":2023,"claim":"Defined a stabilizing post-translational control by TXNIP, which binds the DDIT3 α-helix to reduce its ubiquitination and elevate protein levels in NASH.","evidence":"Co-IP domain mapping, ubiquitination assays, and Txnip knockdown in NASH mouse livers","pmids":["37153733"],"confidence":"High","gaps":["Relationship between TXNIP stabilization and SPOP-mediated turnover not integrated"]},{"year":null,"claim":"How DDIT3 selects among its many dimer partners and subcellular pools to choose between cytoprotective attenuation, differentiation block, and apoptosis in a given stress context remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model of partner/compartment selection","Genome-wide direct DDIT3 binding landscape across stresses incomplete","Quantitative interplay of p38 phosphorylation, SPOP degradation, and TXNIP stabilization in setting DDIT3 levels undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2,8,11,13,19,34]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,8,32,34]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,6,8,24]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,19]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[10,19]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[25]}],"pathway":[{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[4,22,24,30,35]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[5,16,36]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,8,13,31,34]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,11,13]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,28,40]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[21,29]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[25]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[26]}],"complexes":["FUS-DDIT3 fusion oncoprotein","EWS-DDIT3 fusion oncoprotein"],"partners":["CEBPB","CEBPA","ATF3","JUN","JDP2","TXNIP","SPOP","CDK2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P0DPQ6","full_name":"DDIT3 upstream open reading frame protein","aliases":["Alternative DDIT3 protein","AltDDIT3"],"length_aa":34,"mass_kda":4.3,"function":"Product of the upstream open reading frame (uORF) of DDIT3/CHOP that is specifically produced in absence of stress, thereby preventing translation of downstream stress effector DDIT3/CHOP","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P0DPQ6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DDIT3","classification":"Not Classified","n_dependent_lines":35,"n_total_lines":1208,"dependency_fraction":0.028973509933774833},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DDIT3","total_profiled":1310},"omim":[{"mim_id":"620714","title":"DEAFNESS, AUTOSOMAL RECESSIVE 122; DFNB122","url":"https://www.omim.org/entry/620714"},{"mim_id":"618203","title":"TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 4; TMTC4","url":"https://www.omim.org/entry/618203"},{"mim_id":"617109","title":"CREB3 RECRUITMENT FACTOR; CREBRF","url":"https://www.omim.org/entry/617109"},{"mim_id":"615957","title":"SPINOCEREBELLAR ATAXIA 38; SCA38","url":"https://www.omim.org/entry/615957"},{"mim_id":"615319","title":"IMPACT RWD DOMAIN PROTEIN; IMPACT","url":"https://www.omim.org/entry/615319"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DDIT3"},"hgnc":{"alias_symbol":["CHOP10","GADD153","CHOP"],"prev_symbol":[]},"alphafold":{"accession":"P0DPQ6","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P0DPQ6","model_url":"https://alphafold.ebi.ac.uk/files/AF-P0DPQ6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P0DPQ6-F1-predicted_aligned_error_v6.png","plddt_mean":84.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DDIT3","jax_strain_url":"https://www.jax.org/strain/search?query=DDIT3"},"sequence":{"accession":"P0DPQ6","fasta_url":"https://rest.uniprot.org/uniprotkb/P0DPQ6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P0DPQ6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P0DPQ6"}},"corpus_meta":[{"pmid":"11807147","id":"PMC_11807147","title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.","date":"2002","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11807147","citation_count":4490,"is_preprint":false},{"pmid":"14685163","id":"PMC_14685163","title":"Roles of CHOP/GADD153 in endoplasmic reticulum stress.","date":"2004","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/14685163","citation_count":2436,"is_preprint":false},{"pmid":"30662442","id":"PMC_30662442","title":"The C/EBP Homologous Protein (CHOP) Transcription Factor Functions in Endoplasmic Reticulum Stress-Induced Apoptosis and Microbial Infection.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30662442","citation_count":933,"is_preprint":false},{"pmid":"8510758","id":"PMC_8510758","title":"Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8510758","citation_count":799,"is_preprint":false},{"pmid":"8650547","id":"PMC_8650547","title":"Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8650547","citation_count":750,"is_preprint":false},{"pmid":"8754828","id":"PMC_8754828","title":"Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153).","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8754828","citation_count":592,"is_preprint":false},{"pmid":"8125258","id":"PMC_8125258","title":"CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest.","date":"1994","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8125258","citation_count":297,"is_preprint":false},{"pmid":"8898082","id":"PMC_8898082","title":"Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8898082","citation_count":273,"is_preprint":false},{"pmid":"8622660","id":"PMC_8622660","title":"Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8622660","citation_count":264,"is_preprint":false},{"pmid":"34739844","id":"PMC_34739844","title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.","date":"2021","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/34739844","citation_count":256,"is_preprint":false},{"pmid":"8637704","id":"PMC_8637704","title":"Fusion of the EWS and CHOP genes in myxoid liposarcoma.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8637704","citation_count":237,"is_preprint":false},{"pmid":"7588595","id":"PMC_7588595","title":"Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153).","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7588595","citation_count":210,"is_preprint":false},{"pmid":"31537387","id":"PMC_31537387","title":"Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31537387","citation_count":173,"is_preprint":false},{"pmid":"34843406","id":"PMC_34843406","title":"Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA).","date":"2021","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34843406","citation_count":164,"is_preprint":false},{"pmid":"20430872","id":"PMC_20430872","title":"CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis.","date":"2010","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20430872","citation_count":155,"is_preprint":false},{"pmid":"15001576","id":"PMC_15001576","title":"TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15001576","citation_count":147,"is_preprint":false},{"pmid":"9343434","id":"PMC_9343434","title":"gadd153/Chop10, a potential target gene of the transcriptional repressor ATF3.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9343434","citation_count":141,"is_preprint":false},{"pmid":"8764117","id":"PMC_8764117","title":"GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8764117","citation_count":137,"is_preprint":false},{"pmid":"9506442","id":"PMC_9506442","title":"Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo.","date":"1998","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/9506442","citation_count":123,"is_preprint":false},{"pmid":"11146649","id":"PMC_11146649","title":"Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11146649","citation_count":118,"is_preprint":false},{"pmid":"34039602","id":"PMC_34039602","title":"Adaptation to mitochondrial stress requires CHOP-directed tuning of ISR.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/34039602","citation_count":117,"is_preprint":false},{"pmid":"26384350","id":"PMC_26384350","title":"Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26384350","citation_count":106,"is_preprint":false},{"pmid":"22496745","id":"PMC_22496745","title":"Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22496745","citation_count":102,"is_preprint":false},{"pmid":"8662954","id":"PMC_8662954","title":"Physical and functional association between GADD153 and CCAAT/enhancer-binding protein beta during cellular stress.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8662954","citation_count":101,"is_preprint":false},{"pmid":"11360202","id":"PMC_11360202","title":"Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stress-induced cell death.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11360202","citation_count":101,"is_preprint":false},{"pmid":"21402790","id":"PMC_21402790","title":"A CHOP-regulated microRNA controls rhodopsin expression.","date":"2011","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21402790","citation_count":91,"is_preprint":false},{"pmid":"15130668","id":"PMC_15130668","title":"Elevated gadd153/chop expression and enhanced c-Jun N-terminal protein kinase activation sensitizes aged cells to ER stress.","date":"2004","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/15130668","citation_count":88,"is_preprint":false},{"pmid":"27173017","id":"PMC_27173017","title":"miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosis.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27173017","citation_count":78,"is_preprint":false},{"pmid":"12234979","id":"PMC_12234979","title":"GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12234979","citation_count":78,"is_preprint":false},{"pmid":"17981601","id":"PMC_17981601","title":"Chop it, ChIP it, check it: the current status of chromatin immunoprecipitation.","date":"2008","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/17981601","citation_count":78,"is_preprint":false},{"pmid":"32382083","id":"PMC_32382083","title":"Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.","date":"2020","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/32382083","citation_count":77,"is_preprint":false},{"pmid":"34105294","id":"PMC_34105294","title":"DDIT3 Directs a Dual Mechanism to Balance Glycolysis and Oxidative Phosphorylation during Glutamine Deprivation.","date":"2021","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/34105294","citation_count":76,"is_preprint":false},{"pmid":"16880521","id":"PMC_16880521","title":"CCAAT/enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiation.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16880521","citation_count":75,"is_preprint":false},{"pmid":"32815829","id":"PMC_32815829","title":"DDIT3 Immunohistochemistry Is a Useful Tool for the Diagnosis of Myxoid Liposarcoma.","date":"2021","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32815829","citation_count":73,"is_preprint":false},{"pmid":"14684614","id":"PMC_14684614","title":"CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation.","date":"2003","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/14684614","citation_count":73,"is_preprint":false},{"pmid":"25868979","id":"PMC_25868979","title":"A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25868979","citation_count":69,"is_preprint":false},{"pmid":"16651630","id":"PMC_16651630","title":"The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.","date":"2006","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16651630","citation_count":68,"is_preprint":false},{"pmid":"34321322","id":"PMC_34321322","title":"Chop/Ddit3 depletion in β cells alleviates ER stress and corrects hepatic steatosis in mice.","date":"2021","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34321322","citation_count":67,"is_preprint":false},{"pmid":"10330061","id":"PMC_10330061","title":"Urea-associated oxidative stress and Gadd153/CHOP induction.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10330061","citation_count":66,"is_preprint":false},{"pmid":"32135128","id":"PMC_32135128","title":"Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.","date":"2020","source":"The Lancet. Haematology","url":"https://pubmed.ncbi.nlm.nih.gov/32135128","citation_count":64,"is_preprint":false},{"pmid":"26071644","id":"PMC_26071644","title":"C/EBP homologous protein (CHOP) gene deficiency attenuates renal ischemia/reperfusion injury in mice.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26071644","citation_count":63,"is_preprint":false},{"pmid":"19744850","id":"PMC_19744850","title":"CHOP and the endoplasmic reticulum stress response in myelinating glia.","date":"2009","source":"Current opinion in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/19744850","citation_count":62,"is_preprint":false},{"pmid":"28969695","id":"PMC_28969695","title":"Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury.","date":"2017","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/28969695","citation_count":61,"is_preprint":false},{"pmid":"17049495","id":"PMC_17049495","title":"Elevated gadd153/chop expression during resveratrol-induced apoptosis in human colon cancer cells.","date":"2006","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17049495","citation_count":61,"is_preprint":false},{"pmid":"33361422","id":"PMC_33361422","title":"DDIT3 Targets Innate Immunity via the DDIT3-OTUD1-MAVS Pathway To Promote Bovine Viral Diarrhea Virus Replication.","date":"2021","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/33361422","citation_count":60,"is_preprint":false},{"pmid":"23221991","id":"PMC_23221991","title":"Association between arsenic suppression of adipogenesis and induction of CHOP10 via the endoplasmic reticulum stress response.","date":"2012","source":"Environmental health perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/23221991","citation_count":59,"is_preprint":false},{"pmid":"16400006","id":"PMC_16400006","title":"Expression and function of C/EBP homology protein (GADD153) in podocytes.","date":"2006","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16400006","citation_count":55,"is_preprint":false},{"pmid":"35994650","id":"PMC_35994650","title":"Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35994650","citation_count":54,"is_preprint":false},{"pmid":"9322241","id":"PMC_9322241","title":"The growth arrest genes gas5, gas6, and CHOP-10 (gadd153) are expressed in the mouse preimplantation embryo.","date":"1997","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/9322241","citation_count":53,"is_preprint":false},{"pmid":"16434966","id":"PMC_16434966","title":"The C/EBP homologous protein CHOP (GADD153) is an inhibitor of Wnt/TCF signals.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16434966","citation_count":50,"is_preprint":false},{"pmid":"24598693","id":"PMC_24598693","title":"Rosemary (Rosmarinus officinalis) extract modulates CHOP/GADD153 to promote androgen receptor degradation and decreases xenograft tumor growth.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24598693","citation_count":45,"is_preprint":false},{"pmid":"15688424","id":"PMC_15688424","title":"Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.","date":"2005","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15688424","citation_count":45,"is_preprint":false},{"pmid":"10713066","id":"PMC_10713066","title":"Novel interaction between the transcription factor CHOP (GADD153) and the ribosomal protein FTE/S3a modulates erythropoiesis.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10713066","citation_count":44,"is_preprint":false},{"pmid":"15826945","id":"PMC_15826945","title":"Involvement of GADD153 and cardiac ankyrin repeat protein in hypoxia-induced apoptosis of H9c2 cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15826945","citation_count":43,"is_preprint":false},{"pmid":"33691741","id":"PMC_33691741","title":"High dose expression of heme oxigenase-1 induces retinal degeneration through ER stress-related DDIT3.","date":"2021","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/33691741","citation_count":42,"is_preprint":false},{"pmid":"33731886","id":"PMC_33731886","title":"Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas.","date":"2021","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/33731886","citation_count":41,"is_preprint":false},{"pmid":"28637688","id":"PMC_28637688","title":"FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma.","date":"2017","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/28637688","citation_count":40,"is_preprint":false},{"pmid":"22089349","id":"PMC_22089349","title":"DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.","date":"2011","source":"Diagnostic molecular pathology : the American journal of surgical pathology, part B","url":"https://pubmed.ncbi.nlm.nih.gov/22089349","citation_count":37,"is_preprint":false},{"pmid":"22154935","id":"PMC_22154935","title":"Chop (Ddit3) is essential for D469del-COMP retention and cell death in chondrocytes in an inducible transgenic mouse model of pseudoachondroplasia.","date":"2011","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22154935","citation_count":37,"is_preprint":false},{"pmid":"31491992","id":"PMC_31491992","title":"Endoplasmic Reticulum Stress Increases DUSP5 Expression via PERK-CHOP Pathway, Leading to Hepatocyte Death.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31491992","citation_count":36,"is_preprint":false},{"pmid":"24339898","id":"PMC_24339898","title":"CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24339898","citation_count":36,"is_preprint":false},{"pmid":"18463134","id":"PMC_18463134","title":"TRE-dependent transcription activation by JDP2-CHOP10 association.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18463134","citation_count":35,"is_preprint":false},{"pmid":"34087318","id":"PMC_34087318","title":"DDIT3/CHOP promotes autophagy in chondrocytes via SIRT1-AKT pathway.","date":"2021","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34087318","citation_count":33,"is_preprint":false},{"pmid":"10233889","id":"PMC_10233889","title":"Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiation.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10233889","citation_count":33,"is_preprint":false},{"pmid":"24990631","id":"PMC_24990631","title":"Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.","date":"2014","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/24990631","citation_count":31,"is_preprint":false},{"pmid":"35326604","id":"PMC_35326604","title":"DLBCL 1L-What to Expect beyond R-CHOP?","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35326604","citation_count":31,"is_preprint":false},{"pmid":"20043261","id":"PMC_20043261","title":"Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34.","date":"2010","source":"Nutrition and cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20043261","citation_count":30,"is_preprint":false},{"pmid":"35390276","id":"PMC_35390276","title":"The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/35390276","citation_count":29,"is_preprint":false},{"pmid":"12069855","id":"PMC_12069855","title":"Activator protein-1 and CCAAT/enhancer-binding protein mediated GADD153 expression is involved in deoxycholic acid-induced apoptosis.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12069855","citation_count":29,"is_preprint":false},{"pmid":"10542372","id":"PMC_10542372","title":"Upregulation of CHOP-10 (gadd153) expression in the mouse blastocyst as a response to stress.","date":"1999","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/10542372","citation_count":29,"is_preprint":false},{"pmid":"14667815","id":"PMC_14667815","title":"Regulation of aldehyde reductase expression by STAF and CHOP.","date":"2004","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/14667815","citation_count":29,"is_preprint":false},{"pmid":"22441668","id":"PMC_22441668","title":"RNase L controls terminal adipocyte differentiation, lipids storage and insulin sensitivity via CHOP10 mRNA regulation.","date":"2012","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/22441668","citation_count":28,"is_preprint":false},{"pmid":"35459264","id":"PMC_35459264","title":"Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma.","date":"2022","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/35459264","citation_count":28,"is_preprint":false},{"pmid":"27852055","id":"PMC_27852055","title":"Isochaihulactone-induced DDIT3 causes ER stress-PERK independent apoptosis in glioblastoma multiforme cells.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27852055","citation_count":28,"is_preprint":false},{"pmid":"15826835","id":"PMC_15826835","title":"Understanding mesenchymal cancer: the liposarcoma-associated FUS-DDIT3 fusion gene as a model.","date":"2005","source":"Seminars in cancer biology","url":"https://pubmed.ncbi.nlm.nih.gov/15826835","citation_count":26,"is_preprint":false},{"pmid":"10448063","id":"PMC_10448063","title":"CHOP/GADD153 and methionyl-tRNA synthetase (MetRS) genes overlap in a conserved region that controls mRNA stability.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10448063","citation_count":26,"is_preprint":false},{"pmid":"34807015","id":"PMC_34807015","title":"DA-R-EPOCH vs R-CHOP in DLBCL: How do we choose?","date":"2021","source":"Clinical advances in hematology & oncology : H&O","url":"https://pubmed.ncbi.nlm.nih.gov/34807015","citation_count":25,"is_preprint":false},{"pmid":"11084272","id":"PMC_11084272","title":"Phaco-chop versus stop-and-chop nucleotomy for phacoemulsification.","date":"2000","source":"Journal of cataract and refractive surgery","url":"https://pubmed.ncbi.nlm.nih.gov/11084272","citation_count":25,"is_preprint":false},{"pmid":"12082616","id":"PMC_12082616","title":"Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12082616","citation_count":24,"is_preprint":false},{"pmid":"8794898","id":"PMC_8794898","title":"Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells.","date":"1996","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8794898","citation_count":24,"is_preprint":false},{"pmid":"32189359","id":"PMC_32189359","title":"DDIT3 modulates cancer stemness in gastric cancer by directly regulating CEBPβ.","date":"2020","source":"The Journal of pharmacy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32189359","citation_count":23,"is_preprint":false},{"pmid":"20492726","id":"PMC_20492726","title":"Methylation status of DDIT3 gene in chronic myeloid leukemia.","date":"2010","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/20492726","citation_count":23,"is_preprint":false},{"pmid":"24239558","id":"PMC_24239558","title":"A crosstalk between p21 and UPR-induced transcription factor C/EBP homologous protein (CHOP) linked to type 2 diabetes.","date":"2013","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/24239558","citation_count":23,"is_preprint":false},{"pmid":"16631627","id":"PMC_16631627","title":"Doxazosin induces activation of GADD153 and cleavage of focal adhesion kinase in cardiomyocytes en route to apoptosis.","date":"2006","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/16631627","citation_count":23,"is_preprint":false},{"pmid":"31632741","id":"PMC_31632741","title":"DDIT3 (CHOP) contributes to retinal ganglion cell somal loss but not axonal degeneration in DBA/2J mice.","date":"2019","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/31632741","citation_count":22,"is_preprint":false},{"pmid":"33091357","id":"PMC_33091357","title":"A perspective on improving the R-CHOP regimen: from Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise.","date":"2020","source":"The Lancet. Haematology","url":"https://pubmed.ncbi.nlm.nih.gov/33091357","citation_count":22,"is_preprint":false},{"pmid":"32400851","id":"PMC_32400851","title":"Homocysteine induces melanocytes apoptosis via PERK-eIF2α-CHOP pathway in vitiligo.","date":"2020","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/32400851","citation_count":21,"is_preprint":false},{"pmid":"19614958","id":"PMC_19614958","title":"Regulation of GADD153 induced by mechanical stress in cardiomyocytes.","date":"2009","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/19614958","citation_count":21,"is_preprint":false},{"pmid":"12880976","id":"PMC_12880976","title":"Induction of GADD153 and Bak: novel molecular targets of fenretinide-induced apoptosis of neuroblastoma.","date":"2003","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/12880976","citation_count":20,"is_preprint":false},{"pmid":"20017906","id":"PMC_20017906","title":"DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2.","date":"2009","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20017906","citation_count":20,"is_preprint":false},{"pmid":"37153733","id":"PMC_37153733","title":"A novel NEDD4L-TXNIP-CHOP axis in the pathogenesis of nonalcoholic steatohepatitis.","date":"2023","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/37153733","citation_count":20,"is_preprint":false},{"pmid":"10510472","id":"PMC_10510472","title":"Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.","date":"1999","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/10510472","citation_count":20,"is_preprint":false},{"pmid":"35381294","id":"PMC_35381294","title":"DDIT3/CHOP mediates the inhibitory effect of ER stress on chondrocyte differentiation by AMPKα-SIRT1 pathway.","date":"2022","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/35381294","citation_count":19,"is_preprint":false},{"pmid":"24738922","id":"PMC_24738922","title":"DDIT3 overexpression increases odontoblastic potential of human dental pulp cells.","date":"2014","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/24738922","citation_count":19,"is_preprint":false},{"pmid":"27496643","id":"PMC_27496643","title":"Crosstalk between C/EBP homologous protein (CHOP) and glucocorticoid receptor in lung cancer.","date":"2016","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27496643","citation_count":19,"is_preprint":false},{"pmid":"11319142","id":"PMC_11319142","title":"DNA damaging agents increase gadd153 (CHOP-10) messenger RNA levels in bovine preimplantation embryos cultured in vitro.","date":"2001","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/11319142","citation_count":19,"is_preprint":false},{"pmid":"28895119","id":"PMC_28895119","title":"FXR controls CHOP expression in steatohepatitis.","date":"2017","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/28895119","citation_count":18,"is_preprint":false},{"pmid":"19299913","id":"PMC_19299913","title":"Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury.","date":"2009","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19299913","citation_count":17,"is_preprint":false},{"pmid":"20515481","id":"PMC_20515481","title":"Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20515481","citation_count":17,"is_preprint":false},{"pmid":"31886304","id":"PMC_31886304","title":"C/EBP Homologous Protein (CHOP) Activates Macrophages and Promotes Liver Fibrosis in Schistosoma japonicum-Infected Mice.","date":"2019","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/31886304","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52967,"output_tokens":11525,"usd":0.165888,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":22512,"output_tokens":9453,"usd":0.174443,"stage2_stop_reason":"end_turn"},"total_usd":0.340331,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"CHOP (DDIT3) is fused to TLS (FUS), a novel nuclear RNA-binding protein, in human myxoid liposarcoma via t(12;16)(q13;p11) translocation; in the TLS-CHOP fusion protein, the RNA-binding domain of TLS is replaced by the DNA-binding and leucine zipper dimerization domain of CHOP, creating a chimeric oncoprotein.\",\n      \"method\": \"Molecular cloning of translocation-associated gene product, cDNA cloning, CHOP-specific antibody/probe characterization\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — original cloning and structural characterization of fusion protein, replicated in multiple subsequent studies\",\n      \"pmids\": [\"8510758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CHOP (DDIT3) induces G1/S cell cycle arrest; microinjection of CHOP expression plasmids or bacterially-expressed CHOP protein into NIH-3T3 cells blocked progression from G1 to S phase. This effect requires the leucine zipper dimerization domain and the basic region of CHOP. The oncogenic fusion TLS-CHOP fails to cause G1 arrest and interferes with wild-type CHOP-induced arrest. CHOP-C/EBP heterodimers are directed away from classical C/EBP binding sites to unique 'non-classical' sites.\",\n      \"method\": \"Microinjection of expression plasmids and bacterially-expressed protein into synchronized NIH-3T3 cells; BrdU incorporation assay; site-directed mutagenesis of CHOP domains\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct protein microinjection into synchronized cells with mutagenesis, multiple orthogonal readouts\",\n      \"pmids\": [\"8125258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"CHOP (DDIT3) inhibits adipogenesis in 3T3-L1 cells by forming heterodimers with C/EBP alpha and beta, directing the complex away from classical C/EBP binding sites, and suppressing C/EBP alpha and beta gene expression. Ectopic C/EBP alpha expression bypasses CHOP inhibition, indicating CHOP acts upstream by inhibiting C/EBP alpha accumulation rather than only blocking DNA binding.\",\n      \"method\": \"Ectopic expression of CHOP in 3T3-L1 cells; C/EBP alpha rescue experiment; gene expression analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis rescue experiment plus gene expression analysis, replicated in multiple studies\",\n      \"pmids\": [\"7588595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CHOP (DDIT3) is phosphorylated on serine residues 78 and 81 by p38 MAP kinase in vitro; a specific p38 inhibitor (SB203580) abolishes stress-inducible in vivo phosphorylation of CHOP. Phosphorylation on these residues enhances CHOP transcriptional activation activity and is required for CHOP's full inhibitory effect on adipose cell differentiation.\",\n      \"method\": \"In vitro kinase assay with p38; pharmacological inhibitor SB203580 in vivo; site-directed mutagenesis of serine residues; transcriptional activation and differentiation assays\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay combined with mutagenesis and pharmacological inhibition, multiple orthogonal methods\",\n      \"pmids\": [\"8650547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CHOP (GADD153/DDIT3) gene induction is primarily driven by ER stress rather than DNA damage or growth arrest per se. Cells with conditional defects in protein glycosylation induce CHOP at non-permissive temperature; overexpression of ER chaperone BiP/GRP78 attenuates CHOP induction by ER stressors and, unexpectedly, also attenuates induction by methylmethane sulfonate, suggesting prior CHOP induction by MMS was indirect via ER stress.\",\n      \"method\": \"Temperature-sensitive mutant cell lines (CHO K12, BHK tsBN7); BiP/GRP78 overexpression; stress-agent panel; gene expression analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (conditional mutant) and molecular (BiP overexpression) approaches, multiple cell systems\",\n      \"pmids\": [\"8754828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells (>60% cell death at 72h) in a p53-independent manner. Apoptosis requires the leucine zipper domain but neither the intact basic region nor the trans-activation domain. CHOP-mediated apoptosis is accompanied by downregulation of Bcl-2 mRNA, and Bcl-2 overexpression delays the process.\",\n      \"method\": \"Conditional CHOP expression in M1 cells; site-directed mutagenesis of CHOP domains; Bcl-2 overexpression rescue; apoptosis assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain mutagenesis, rescue with Bcl-2, p53-null cell context, multiple orthogonal approaches\",\n      \"pmids\": [\"8898082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"GADD153 (CHOP/DDIT3) forms endogenous heterodimers with C/EBP-beta in arsenite-treated PC12 cells, as demonstrated by co-immunoprecipitation. GADD153 overexpression inhibits C/EBP-beta-mediated transactivation of the GADD153 promoter, establishing an autoregulatory feedback loop in which GADD153 attenuates its own expression during stress via sequestration of C/EBP-beta.\",\n      \"method\": \"Co-immunoprecipitation of endogenous proteins from arsenite-treated PC12 cells; transient transfection reporter assays; EMSA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — endogenous co-IP combined with reporter assays and EMSA, multiple orthogonal methods\",\n      \"pmids\": [\"8662954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"GADD153 (CHOP) inhibits C/EBP transcriptional activity in 32D cl3 myeloid cells when overexpressed, reducing trans-activation by endogenous C/EBPs. High-level CHOP expression sensitizes cells to apoptosis when cells are transferred to G-CSF, suggesting CHOP-mediated inhibition of C/EBP-dependent survival signals.\",\n      \"method\": \"Ectopic CHOP overexpression in 32D cl3 cells; trans-activation assays; apoptosis assays under IL-3 vs G-CSF conditions\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, clean overexpression with defined cellular phenotype but limited mechanistic resolution\",\n      \"pmids\": [\"8764117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"ATF3 forms a non-functional heterodimer with GADD153/Chop10 (DDIT3): the ATF3-GADD153 heterodimer does not bind the ATF/CRE consensus site and does not repress transcription, in contrast to the ATF3 homodimer. This provides a mechanism by which GADD153 inhibits ATF3 function.\",\n      \"method\": \"Heterodimerization assays; DNA binding assays; transcriptional repression assays in transfected cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro DNA-binding assays combined with functional transcriptional assays demonstrating loss of function of heterodimer\",\n      \"pmids\": [\"8622660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"ATF3 represses the expression of its inhibitor gadd153/Chop10 (DDIT3) by binding to two sites in the GADD153 promoter: an AP-1 site and a C/EBP-ATF composite site. ATF3 overexpression reduces endogenous GADD153 mRNA, establishing a mutual negative regulatory loop between ATF3 and GADD153.\",\n      \"method\": \"Promoter-reporter transfection assays; in vitro transcription assay; EMSA mapping of two ATF3 binding sites in GADD153 promoter; overexpression of ATF3 with endogenous GADD153 mRNA measurement; in vivo CCl4 model\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — promoter mapping by EMSA, in vitro transcription, in vivo overexpression with endogenous mRNA readout, multiple orthogonal methods\",\n      \"pmids\": [\"9343434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CHOP (GADD153) interacts with ribosomal protein FTE/S3a (non-C/EBP binding partner). Bacterially expressed His-CHOP and in vitro translated FTE/S3a-Gal4 fusion protein co-immunoprecipitated with anti-CHOP antibodies; endogenous co-IP in Rauscher erythroleukemia cells confirmed the in vivo interaction. CHOP and FTE/S3a co-localize in both cytosol and nuclei. FTE/S3a overexpression inhibits erythroid differentiation, and this inhibition is reversed by simultaneous CHOP overexpression.\",\n      \"method\": \"Bacterially expressed protein co-immunoprecipitation; endogenous co-IP; Western blot co-localization; functional differentiation rescue assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP (bacterial + endogenous), functional rescue assay, co-localization, multiple orthogonal methods\",\n      \"pmids\": [\"10713066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CHOP (GADD153) physically interacts with TCF transcription factors, preventing TCF from binding its DNA recognition site, thereby inhibiting Wnt/TCF-dependent transcription. In Xenopus embryos, CHOP mRNA injection suppresses dorsal organizer formation and inhibits secondary axis induction by Wnt-8, Dishevelled, beta-catenin, or TCF-VP16. This inhibitory function requires the N-terminal transactivation domain of CHOP, not the C-terminal dimerization domain.\",\n      \"method\": \"CHOP-TCF binding assay; TCF-dependent luciferase reporter assays in human cell lines; Xenopus embryo injection; domain deletion mutants of CHOP\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — DNA binding assay, reporter assays in multiple systems, in vivo Xenopus functional epistasis, domain mutagenesis\",\n      \"pmids\": [\"16434966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TRAF7 specifically interacts with MEKK3 and potentiates MEKK3-mediated CHOP (DDIT3) and AP1 activation. Depletion of TRAF7 by antisense RNA inhibits MEKK3-mediated CHOP activation. Domain mapping shows TRAF7 potentiates CHOP activation and induces apoptosis through distinct domains.\",\n      \"method\": \"Co-immunoprecipitation; antisense RNA depletion; reporter assays for CHOP activation; domain mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, co-IP plus functional reporter and antisense knockdown, but limited mechanistic detail on CHOP regulation specifically\",\n      \"pmids\": [\"15001576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CHOP (DDIT3) forms heterodimers with C/EBP-beta and inhibits both the DNA-binding activity and Runx2-binding activity of C/EBP-beta, leading to inhibition of osteocalcin gene transcription and inhibition of osteoblast differentiation. CHOP-deficient osteoblasts differentiate more strongly than wild-type counterparts.\",\n      \"method\": \"Overexpression of CHOP in primary osteoblasts; CHOP-knockout osteoblast differentiation assays (alkaline phosphatase, calcified nodule formation); heterodimerization assay; DNA binding/Runx2-binding inhibition assays; reporter assay for osteocalcin promoter\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO cells, overexpression, biochemical binding assays, promoter assays, multiple orthogonal methods\",\n      \"pmids\": [\"16880521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CHOP/DDIT3 overexpression in osteoblastic ST-2 stromal cells (retroviral transduction) enhances osteoblastic differentiation, accelerates mineralized nodule formation, and increases osteocalcin/alkaline phosphatase expression. CHOP overexpression decreases C/EBP binding to consensus sequences by interacting with C/EBP alpha and beta (confirmed by EMSA/supershift assay), and enhances BMP-2/Smad signaling.\",\n      \"method\": \"Retroviral overexpression; EMSA/supershift assays for C/EBP interaction; Smad signaling assays; differentiation marker expression\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA/supershift directly demonstrating C/EBP interaction, functional differentiation phenotype, single lab\",\n      \"pmids\": [\"14684614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DDIT3 (CHOP) and the fusion oncoprotein FUS-DDIT3 both bind cyclin-dependent kinase 2 (CDK2). In addition, CDK2 showed increased affinity for cytoskeletal proteins in cells expressing FUS-DDIT3 and DDIT3.\",\n      \"method\": \"Co-immunoprecipitation; interaction screen for CDK2 binding among G1 cyclins and CDKs\",\n      \"journal\": \"BMC cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP screen, single lab, limited functional follow-up\",\n      \"pmids\": [\"20017906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CHOP (GADD153) physically interacts with the AP-1 complex protein c-Jun upon palmitate treatment; a CHOP:phospho-c-Jun heteromeric complex binds to the AP-1 consensus binding sequence in the PUMA promoter. CHOP knockdown reduces PUMA induction and Bax activation and attenuates palmitate-induced apoptosis. No functional CHOP binding sites were identified in the PUMA promoter, but CHOP acts via cooperation with AP-1.\",\n      \"method\": \"Co-immunoprecipitation of CHOP and phospho-c-Jun; ChIP with PUMA promoter AP-1 site; shRNA knockdown of CHOP; PUMA mRNA/protein and Bax activation assays\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, ChIP at PUMA promoter, and loss-of-function with defined molecular phenotype, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"20430872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CHOP10 (DDIT3) associates with JDP2 via leucine zipper motifs; the JDP2-CHOP10 complex binds TPA response elements (TRE) both in vitro and in vivo (but not CRE sites) and strongly activates TRE-dependent transcription. JDP2 overexpression counteracts CHOP10 pro-apoptotic activity and increases cell viability following ER stress.\",\n      \"method\": \"Co-immunoprecipitation; in vitro and in vivo DNA binding assays; luciferase reporter assays; domain mapping; cell viability assay under ER stress\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo DNA binding plus reporter assays and co-IP, single lab\",\n      \"pmids\": [\"18463134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CHOP (DDIT3) directly regulates miR-708 expression: CHOP and miR-708 are co-encoded (miR-708 is within an intron of the CHOP-regulated gene Odz4) and co-expressed in brain and eye. CHOP-dependent miR-708 induction during ER stress is functionally validated—miR-708 directly targets rhodopsin mRNA, reducing rhodopsin protein levels through loss- and gain-of-function experiments.\",\n      \"method\": \"Genome-wide miRNA expression profiling; bioinformatics; miR-708 loss- and gain-of-function experiments; rhodopsin target validation; CHOP-dependent co-regulation assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide profiling with loss- and gain-of-function validation, target confirmed by multiple experiments, single lab\",\n      \"pmids\": [\"21402790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DDIT3 (CHOP) has distinct cytoplasmic and nuclear functions: cytoplasmic DDIT3 inhibits cell migration and regulates 94 target genes; nuclear DDIT3 causes G1 cell cycle arrest and regulates 81 additional genes. Only 3 genes are regulated by both localizations. Promoters of target genes show no common sequence motifs, indicating DDIT3 acts via different heterodimer partners in each compartment.\",\n      \"method\": \"Tamoxifen-inducible DDIT3 expression constructs with cytoplasmic vs nuclear localization; genome-wide microarray expression analysis; cell migration assays; cell cycle analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide expression analysis with inducible localization-specific constructs, confirmed by functional assays, single lab\",\n      \"pmids\": [\"22496745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RNase L associates with CHOP10 (DDIT3) mRNA and regulates its stability; in RNase L knockout MEFs, CHOP10 mRNA is stabilized, maintaining preadipocyte state and impairing terminal adipocyte differentiation. Ectopic RNase L restores CHOP10 mRNA instability and rescues adipocyte differentiation, lipid storage, and insulin sensitivity.\",\n      \"method\": \"RNase L-knockout MEFs; RNase L-CHOP10 mRNA association assay; ectopic RNase L rescue; CHOP10 siRNA in knockout cells; in vivo aged RNase L KO mice\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO cells, ectopic rescue, direct mRNA association, siRNA epistasis, in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"22441668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DDIT3 (CHOP) is a bona fide substrate for the SPOP-CUL3-RBX1 E3 ubiquitin ligase complex; SPOP recognizes a Ser/Thr-rich degron in the transactivation domain of DDIT3 and triggers its degradation via the ubiquitin-proteasome pathway. Prostate cancer-associated mutants of SPOP are defective in promoting DDIT3 degradation.\",\n      \"method\": \"Ubiquitination assays; proteasome inhibitor experiments; SPOP interaction/binding assays; degron mapping; prostate cancer SPOP mutant analysis\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ubiquitination assay with degron mapping, proteasome-dependent degradation shown, disease-mutant validation\",\n      \"pmids\": [\"24990631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CHOP/GADD153 (DDIT3)-dependent apoptosis involves direct CHOP-mediated induction of miR-216b expression. miR-216b accumulation requires PERK-dependent induction of CHOP and is antagonized by IRE1. miR-216b directly targets c-Jun mRNA, thereby reducing AP-1-dependent transcription and sensitizing cells to ER stress-dependent apoptosis.\",\n      \"method\": \"CHOP loss-of-function; PERK pathway analysis; IRE1 modulation; miR-216b gain/loss of function; c-Jun targeting validation; AP-1 reporter assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — PERK-CHOP-miR-216b axis established by loss-of-function at multiple nodes, direct target (c-Jun) validated, mechanistic pathway defined\",\n      \"pmids\": [\"27173017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DDIT3 (CHOP) and JUN are independently regulated pro-death signaling molecules in retinal ganglion cells (RGCs) after optic nerve crush. Combined deficiency of Jun and Ddit3 provides significantly greater long-term RGC somal protection than either single knockout; Ddit3 deficiency does not alter JUN expression after injury, indicating the two pathways are independent. Despite somal protection, combined loss does not prevent axonal degeneration.\",\n      \"method\": \"Single and double knockout mice (Jun-/-, Ddit3-/-, Jun/Ddit3-/-); optic nerve crush model; RGC survival quantification at multiple time points; compound action potential recordings for axonal assessment\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double-knockout genetic epistasis with multiple time points and functional readouts, axonal vs somal degeneration distinguished\",\n      \"pmids\": [\"28969695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DDIT3 (CHOP) acts as a rheostat that attenuates prolonged ISR (integrated stress response) during mitochondrial dysfunction by interacting with C/EBPβ to adjust ATF4 levels. CHOP-C/EBPβ interaction prevents overactivation of the ATF4-regulated transcriptional program. Failure of this interaction switches ISR from acute to chronic state, causing respiratory chain deficiency, energy crisis, and premature death. This identifies a role for CHOP as an attenuator (not activator) of mitochondrial stress response.\",\n      \"method\": \"Transgenic mice with mitochondrial cardiomyopathy; CHOP-C/EBPβ interaction studies; ATF4 level measurements; metabolic analysis; translation efficiency (Ribo-Seq/RNA-Seq); cardiac function assessment\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic model, biochemical interaction assay, mechanistic epistasis with ATF4/C/EBPβ, multiple orthogonal methods\",\n      \"pmids\": [\"34039602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DDIT3 (CHOP) directs a dual metabolic mechanism during glutamine deprivation: (1) nuclear DDIT3 promotes glycolysis and ATP production by suppressing the negative glycolytic regulator TIGAR; (2) a pool of DDIT3 translocates to mitochondria and suppresses oxidative phosphorylation through LONP1-mediated down-regulation of COQ9 and COX4, thereby dampening reactive oxygen species from glutamine withdrawal.\",\n      \"method\": \"DDIT3 induction during glutamine deprivation; TIGAR suppression assay; subcellular fractionation showing mitochondrial DDIT3 localization; LONP1 interaction; COQ9/COX4 regulation; metabolic flux analysis\",\n      \"journal\": \"Advanced science (Weinheim, Baden-Wurttemberg, Germany)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — subcellular fractionation with mechanistic follow-up on two distinct pathways, single lab\",\n      \"pmids\": [\"34105294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DDIT3 (CHOP) inhibits innate antiviral immunity via a DDIT3-OTUD1-MAVS pathway: DDIT3 promotes NF-κB-dependent OTUD1 expression; OTUD1 deubiquitinates and stabilizes Smurf1; Smurf1 then degrades MAVS via ubiquitination, ultimately suppressing type I interferon production. DDIT3 knockout in mice promotes antiviral innate immune response.\",\n      \"method\": \"DDIT3 overexpression/knockdown; NF-κB pathway analysis; OTUD1 deubiquitination assay; Smurf1 stabilization; MAVS ubiquitination/degradation assay; DDIT3 KO mice with BVDV infection\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical ubiquitination/deubiquitination assays with genetic KO validation in vivo, but in MDBK (bovine) cells with partial validation in mouse\",\n      \"pmids\": [\"33361422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Chop/Ddit3 depletion in pancreatic β cells reduces ER Ca2+ buffering capacity and modulates glucose-induced islet Ca2+ oscillations, leading to transcriptional changes of ER chaperone profile ('ER remodeling'), delayed glucose-stimulated insulin secretion, and prevention of liver steatosis in HFD-fed mice. A GLP1-conjugated Chop antisense oligonucleotide recapitulates these effects.\",\n      \"method\": \"β cell-specific Chop knockout mice; HFD model; Ca2+ flux measurements in islets; ER chaperone expression profiling; liver triglyceride quantification; GLP1-ASO therapeutic approach\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific KO with mechanistic follow-up (Ca2+ dynamics, chaperone profiling), in vivo validation, therapeutic validation with ASO\",\n      \"pmids\": [\"34321322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The FUS::DDIT3 fusion oncoprotein inhibits BAF (mSWI/SNF) complex-mediated chromatin remodeling at adipogenic enhancer sites by sequestering the adipogenic transcription factor CEBPB from the genome. BAF chromatin occupancy and gene expression in FUS::DDIT3-expressing cells resembles SMARCB1-deficient tumor types.\",\n      \"method\": \"Co-immunoprecipitation (CEBPB sequestration); ChIP-seq for BAF complex occupancy; ATAC-seq for chromatin accessibility; transcriptome sequencing; small-molecule BAF ATPase inhibition; FUS::DDIT3 knockdown\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — ChIP-seq, ATAC-seq, co-IP, and functional inhibitor experiments defining mechanism by which fusion protein inhibits chromatin remodeling\",\n      \"pmids\": [\"35390276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TXNIP protein associates with the α-helix domain of CHOP (DDIT3) via its C-terminus, decreasing CHOP ubiquitination and increasing CHOP protein stability. In NASH, accumulation of TXNIP (due to impaired NEDD4L-mediated ubiquitination) leads to elevated CHOP protein levels (not mRNA). Knockdown of Txnip in NASH mouse livers suppresses CHOP expression and downstream apoptotic signaling.\",\n      \"method\": \"Co-immunoprecipitation (TXNIP-CHOP); ubiquitination assays for CHOP; gain-/loss-of-function studies in vitro and in vivo; NASH mouse models; adenovirus-mediated Txnip shRNA liver knockdown\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP mapping domain interaction, ubiquitination assay showing stabilization mechanism, in vivo validation in multiple NASH models\",\n      \"pmids\": [\"37153733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Chop (Ddit3) is essential for D469del-COMP retention and premature chondrocyte cell death in pseudoachondroplasia; crossing the D469del-COMP transgenic mouse onto a Chop null background alleviates both D469del-COMP intracellular retention and premature chondrocyte cell death, placing CHOP as a critical effector of ER stress-induced mutant protein retention.\",\n      \"method\": \"D469del-COMP transgenic mouse crossed with Chop-null (Ddit3-null) mice; immunostaining; transcriptome analysis; qRT-PCR; apoptosis assays\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis (double mutant rescue), in vivo model, multiple readouts\",\n      \"pmids\": [\"22154935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"FUS-DDIT3 fusion oncogene induces C/EBPβ-mediated IL-6 expression in fibrosarcoma cells; siRNA knockdown of CEBPB transcripts abolishes the effect of FUS-DDIT3 on IL-6 expression. Chromatin immunoprecipitation reveals direct interaction between the IL-6 promoter and C/EBPβ in DDIT3/FUS-DDIT3-expressing cells. DDIT3 and FUS-DDIT3 show opposite effects on IL-8 transcription.\",\n      \"method\": \"Stable transfection of DDIT3-GFP and FUS-DDIT3-GFP; microarray; siRNA knockdown of CEBPB; RT-PCR; ChIP for C/EBPβ at IL-6 promoter\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus siRNA epistasis and microarray in isogenic transfectants, single lab\",\n      \"pmids\": [\"15688424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The GADD153 promoter is transactivated by ETS1 and FLI-1 transcription factors via a single EBS (ETS binding site) in the human GADD153 promoter. ETS1 and FLI-1 strongly activate GADD153 EBS-linked reporter transcription; ETS2 produces only weak induction.\",\n      \"method\": \"Promoter-reporter (CAT) assays; EMSA for ETS1/FLI-1 binding to GADD153 EBS; ectopic expression of ETS1, ETS2, FLI-1\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — reporter assay and EMSA, single lab, no endogenous gene validation\",\n      \"pmids\": [\"10510472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CHOP (GADD153) protein binds to and inhibits the CHOP promoter's C/EBP-binding site by interacting with C/EBP-beta, providing an autoregulatory loop. In aged rat hepatocytes, higher baseline GADD153/CHOP expression is correlated with enhanced JNK activation and greater sensitivity to ER stress-induced cell death; pharmacologic JNK inhibition decreases GADD153 expression, while p38 inhibition enhances it.\",\n      \"method\": \"Hepatocyte isolation from young and aged rats; ER stress inducers (TG, TM); JNK and p38 pharmacological inhibitors; GADD153 expression measurement; cell death assays\",\n      \"journal\": \"Experimental gerontology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, pharmacological approach with defined pathway dissection (JNK vs p38 regulation of GADD153)\",\n      \"pmids\": [\"15130668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DDIT3/CHOP directly binds the SIRT1 promoter to promote its transcription (demonstrated by ChIP); SIRT1 then enhances autophagic activity. DDIT3-induced autophagy in ATDC5 chondrocytes proceeds via the SIRT1-AKT pathway, as SIRT1 inhibition or knockdown reverses DDIT3 overexpression effects on autophagy markers (Beclin1, LC3B, p62). DDIT3/CHOP KO mice show decreased autophagic markers in tibial growth plate.\",\n      \"method\": \"ChIP assay for DDIT3 binding to SIRT1 promoter; qRT-PCR; Western blot; DDIT3 overexpression/knockdown in ATDC5 cells; DDIT3 KO mice; autophagic flux assay with chloroquine; SIRT1 inhibitor/activator experiments\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms direct promoter binding, KO mice, pharmacological epistasis, autophagic flux assay, multiple orthogonal methods\",\n      \"pmids\": [\"34087318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DDIT3/CHOP contributes to retinal photoreceptor cell degeneration induced by high-level HMOX1 expression via ER stress; genetic deletion of Ddit3 in knockout mice prevents photoreceptor cell degeneration caused by high-level HMOX1, placing DDIT3 downstream of HMOX1-induced ER stress.\",\n      \"method\": \"AAV-mediated HMOX1 overexpression at two doses; Ddit3 knockout mice; RNA-seq; qPCR; Western blot; TUNEL assay; ERG; immunostaining\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic rescue (Ddit3 KO), RNA-seq pathway analysis, multiple functional readouts\",\n      \"pmids\": [\"33691741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CHOP (DDIT3) up-regulation induced by albuminuria drives TXNIP shuttling from nucleus to mitochondria, where TXNIP promotes mitochondrial ROS production, oxidizes Trx2, liberates TXNIP to activate NLRP3 inflammasome and ASK1-dependent apoptosis. CHOP deletion (Chop-/- mice) suppresses TXNIP mitochondrial translocation, NLRP3 inflammasome activation, and p-ASK1-dependent apoptosis in nephrotic syndrome.\",\n      \"method\": \"Chop-/- and Txnip-/- mice; nephrotic syndrome model; subcellular fractionation of TXNIP; 68Ga-Galuminox molecular imaging of mitochondrial ROS; NLRP3/ASK1 activation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO models, subcellular fractionation, in vivo molecular imaging, multiple downstream pathway assays\",\n      \"pmids\": [\"35994650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The CHOP and methionyl-tRNA synthetase (MetRS) genes overlap tail-to-tail at the 12q13 locus over a 55-bp region sharing complementary 3' UTR sequence containing an AU-rich element (ARE) that controls mRNA stability. The CHOP 3'UTR confers lower reporter activity than controls, and deleting the overlapping MetRS-complementary region increases reporter activity, demonstrating functional mRNA destabilization by the ARE.\",\n      \"method\": \"PCR mapping of gene overlap; luciferase reporter assay with CHOP 3'UTR constructs; deletion mutagenesis; transfection in NIH-3T3 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — reporter assay with deletion mapping showing functional ARE in CHOP 3'UTR, single lab\",\n      \"pmids\": [\"10448063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"NF-κB (p65 subunit specifically, not p50) represses GADD153/CHOP promoter activity, providing a cellular defense against ER stress-induced apoptosis. p65-/- MEFs show greater GADD153 expression and increased sensitivity to ER stress agents; transient transfection assays confirm p65 represses the GADD153 promoter.\",\n      \"method\": \"Transient transfection GADD153 promoter-reporter assays; p65-/- knockout MEFs; pharmacological NF-κB inhibitor (parthenolide); cell viability assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO cells combined with promoter reporter and pharmacological inhibitor, mechanistic specificity for p65 vs p50 established\",\n      \"pmids\": [\"11360202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The EWS gene N-terminal region can substitute for the FUS N-terminal region in a CHOP fusion oncoprotein in myxoid liposarcoma, establishing that the oncogenic potential resides in the CHOP portion and that the two N-terminal FUS/EWS domains have common or similar oncogenic potential when fused to CHOP.\",\n      \"method\": \"Identification of EWS/CHOP chimeric gene by translocation analysis t(12;22); molecular cloning of EWS-CHOP fusion transcript in two MLS cases\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — molecular cloning of fusion gene in patient tumors, mechanistic inference from natural experiment, no in vitro functional assay\",\n      \"pmids\": [\"8637704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FUS-DDIT3 fusion oncoprotein drives aberrant IGF-IR/PI3K/Akt pathway activity through transcriptional induction of the IGF2 gene; RNAi-mediated FUS-DDIT3 knockdown in myxoid liposarcoma cells leads to inactivation of IGF-IR/PI3K/Akt signaling with diminished IGF2 mRNA expression.\",\n      \"method\": \"FUS-DDIT3 overexpression and RNAi knockdown; IGF2 mRNA quantification; IGF-IR/PI3K/Akt pathway signaling readouts; IGF-IR inhibitor treatment in vitro and in vivo (CAM model)\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi knockdown with pathway-specific readouts, transcriptional target identified, single lab with in vivo validation\",\n      \"pmids\": [\"28637688\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DDIT3 (CHOP/GADD153) is a stress-inducible bZIP transcription factor of the C/EBP family that is primarily activated by ER stress (via PERK pathway), phosphorylated on Ser78/81 by p38 MAP kinase to enhance its transcriptional activity, and degraded via the SPOP-CUL3-RBX1 ubiquitin-proteasome pathway and stabilized by TXNIP; it acts principally as a dominant-negative inhibitor of C/EBP family members by forming heterodimers directed away from classical C/EBP sites, thereby blocking adipogenesis and osteoblast differentiation, inducing G1/S cell cycle arrest via CDK2 interaction, and promoting apoptosis by suppressing Bcl-2, co-operating with AP-1/c-Jun to induce PUMA, and driving miR-216b-mediated c-Jun suppression; DDIT3 also inhibits Wnt/TCF signaling by binding TCF factors, attenuates the mitochondrial integrated stress response by interacting with C/EBPβ to limit ATF4 activation, directs metabolic reprogramming during glutamine deprivation through both nuclear (TIGAR suppression/glycolysis) and mitochondrial (LONP1/COQ9/COX4/OXPHOS suppression) pools, and suppresses innate antiviral immunity via a DDIT3-OTUD1-Smurf1-MAVS degradation axis, while its fusion with FUS or EWS generates oncoproteins that sequester CEBPB from chromatin and activate IGF2/IGF-IR signaling to drive myxoid liposarcoma.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DDIT3 (CHOP/GADD153) is a stress-inducible bZIP transcription factor whose expression is driven primarily by ER stress rather than by DNA damage or growth arrest per se [#4], and which executes cell-fate decisions during the stress response chiefly by dimerizing with C/EBP family members and redirecting them away from classical C/EBP sites to non-classical targets [#1, #2]. Through heterodimerization with C/EBPα and C/EBPβ, DDIT3 suppresses C/EBP-dependent transcription and blocks adipogenic and osteoblastic differentiation [#2, #13], and it forms autoregulatory and inhibitory heterodimers with C/EBPβ and ATF3 that limit its own induction and disable partner DNA binding [#6, #8]. Functionally DDIT3 imposes G1/S cell cycle arrest, an activity requiring its leucine zipper and basic region [#1], and drives apoptosis through a domain-separable program that downregulates Bcl-2 [#5] and, via cooperation with phospho-c-Jun/AP-1, induces the proapoptotic gene PUMA [#16]; it further amplifies death signaling through PERK-dependent induction of miR-216b, which targets c-Jun [#22]. DDIT3 activity is tuned post-translationally: p38 MAP kinase phosphorylates Ser78/Ser81 to enhance its transcriptional and differentiation-inhibitory activity [#3], it is targeted for proteasomal degradation by the SPOP-CUL3-RBX1 E3 ligase via a degron in its transactivation domain [#21], and it is stabilized by TXNIP binding that reduces its ubiquitination [#29]. Beyond classical transcriptional repression, DDIT3 partitions between cytoplasmic and nuclear pools with distinct target genes and phenotypes [#19], serves as an attenuator (rheostat) of the mitochondrial integrated stress response by interacting with C/EBPβ to constrain ATF4 [#24], and directs metabolic reprogramming during glutamine deprivation through nuclear suppression of TIGAR and a mitochondrial pool acting via LONP1 to suppress OXPHOS components [#25]. In vivo, DDIT3 is a required effector of ER-stress-driven cell death in pseudoachondroplasia chondrocytes [#30], photoreceptor degeneration [#35], and TXNIP-dependent mitochondrial ROS/NLRP3/ASK1 injury in nephrotic syndrome [#36], and it suppresses innate antiviral immunity through a DDIT3-OTUD1-Smurf1-MAVS degradation axis [#26]. Chromosomal translocations fuse DDIT3 to FUS or EWS to generate myxoid liposarcoma oncoproteins that sequester CEBPB from chromatin and BAF-remodeled adipogenic enhancers and activate IGF2/IGF-IR signaling [#0, #28, #40].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established the disease relevance of DDIT3 by showing it is the recurrent fusion partner in myxoid liposarcoma, defining a chimeric oncoprotein in which the FUS RNA-binding domain is replaced by the DDIT3 DNA-binding/leucine-zipper module.\",\n      \"evidence\": \"Molecular cloning of the t(12;16) translocation product and cDNA characterization\",\n      \"pmids\": [\"8510758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the transcriptional or chromatin mechanism of the fusion\", \"No functional comparison to wild-type DDIT3\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Defined a core cellular function by showing DDIT3 imposes G1/S arrest dependent on its dimerization and basic domains, and that the oncogenic fusion lacks this activity and dominantly interferes with it.\",\n      \"evidence\": \"Microinjection of plasmid and bacterial protein into synchronized NIH-3T3 cells with BrdU readout and domain mutagenesis\",\n      \"pmids\": [\"8125258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cell-cycle target genes not identified\", \"Non-classical DNA sites not mapped\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Resolved the mechanism of differentiation block by showing DDIT3 heterodimerizes with C/EBPα/β, redirects them off classical sites, and acts upstream by suppressing C/EBPα accumulation.\",\n      \"evidence\": \"Ectopic expression in 3T3-L1 adipocytes with C/EBPα rescue and expression analysis\",\n      \"pmids\": [\"7588595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the non-classical site sequences\", \"Mechanism of C/EBPα suppression at gene level unresolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identified the upstream activating stimulus and post-translational control, establishing that DDIT3 induction is driven by ER stress and that p38 phosphorylation of Ser78/81 enhances its activity.\",\n      \"evidence\": \"Temperature-sensitive glycosylation mutants and BiP overexpression for induction; in vitro p38 kinase assay, SB203580, and serine mutagenesis for phosphorylation\",\n      \"pmids\": [\"8754828\", \"8650547\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream ER-stress sensor pathway not connected at this stage\", \"How phosphorylation alters dimer partner choice unresolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Established DDIT3 as a proapoptotic factor with a domain-separable, p53-independent program linked to Bcl-2 downregulation, and as an inhibitor of C/EBP-dependent survival signals.\",\n      \"evidence\": \"Conditional expression in M1 and 32D myeloid cells, domain mutagenesis, Bcl-2 rescue, and trans-activation/apoptosis assays\",\n      \"pmids\": [\"8898082\", \"8764117\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional link to Bcl-2 not established\", \"Apoptotic effectors downstream not defined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Defined dimerization-based inhibitory mechanisms by showing DDIT3 forms non-functional heterodimers with C/EBPβ (autoregulatory feedback) and with ATF3, abolishing partner DNA binding.\",\n      \"evidence\": \"Endogenous co-IP, EMSA, and reporter assays in arsenite-treated PC12 cells; heterodimerization and DNA-binding assays for ATF3\",\n      \"pmids\": [\"8662954\", \"8622660\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of each heterodimer not quantified\", \"Partner selectivity rules not defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Placed DDIT3 in a mutual negative regulatory loop with ATF3, which represses the DDIT3 promoter via AP-1 and C/EBP-ATF composite sites.\",\n      \"evidence\": \"Promoter mapping by EMSA, in vitro transcription, ATF3 overexpression, and a CCl4 in vivo model\",\n      \"pmids\": [\"9343434\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts where the loop dominates not defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Extended DDIT3 beyond C/EBP biology by identifying a non-bZIP partner (ribosomal protein FTE/S3a) and demonstrating functional rescue of erythroid differentiation.\",\n      \"evidence\": \"Reciprocal co-IP (bacterial and endogenous), co-localization, and differentiation rescue in erythroleukemia cells\",\n      \"pmids\": [\"10713066\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of the cytosolic interaction unclear\", \"Whether interaction affects transcription unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Characterized a cis-acting control on DDIT3 mRNA stability through an AU-rich element in a 3'UTR region overlapping the MetRS gene.\",\n      \"evidence\": \"Gene-overlap mapping and luciferase reporter assays with 3'UTR deletion constructs in NIH-3T3 cells\",\n      \"pmids\": [\"10448063\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trans-acting factors binding the ARE not identified\", \"Endogenous transcript stability not directly measured\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified transcriptional repression of DDIT3 by NF-κB p65 as a cytoprotective brake against ER-stress apoptosis.\",\n      \"evidence\": \"GADD153 promoter reporters, p65-/- MEFs, and parthenolide treatment with viability assays\",\n      \"pmids\": [\"11360202\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of p65 promoter repression not defined\", \"p50 vs p65 specificity basis unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Broadened DDIT3 signaling reach by showing it binds TCF factors to inhibit Wnt/TCF transcription, an activity requiring the N-terminal transactivation domain rather than the dimerization domain.\",\n      \"evidence\": \"TCF-binding and reporter assays plus Xenopus axis-induction epistasis with domain deletion mutants\",\n      \"pmids\": [\"16434966\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian developmental relevance not tested\", \"Direct TCF target genes affected not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapped additional regulators of DDIT3 expression: TRAF7-MEKK3 signaling activates DDIT3, while ETS1/FLI-1 transactivate the promoter via an ETS binding site.\",\n      \"evidence\": \"Co-IP/antisense and reporter assays for TRAF7-MEKK3; promoter-reporter and EMSA for ETS1/FLI-1\",\n      \"pmids\": [\"15001576\", \"10510472\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous DDIT3 induction by ETS factors not validated\", \"Physiological stimuli engaging TRAF7-MEKK3-DDIT3 unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed how the fusion oncoprotein diverges from wild-type DDIT3, with FUS-DDIT3 driving CEBPB-dependent IL-6 induction and opposite effects on IL-8.\",\n      \"evidence\": \"Isogenic DDIT3-GFP and FUS-DDIT3-GFP transfectants with microarray, CEBPB siRNA epistasis, and ChIP at the IL-6 promoter\",\n      \"pmids\": [\"15688424\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How fusion redirects CEBPB to target promoters not yet mechanistically defined here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established DDIT3 control of osteoblast differentiation via C/EBPβ inhibition, with context-dependent outcomes across cell systems.\",\n      \"evidence\": \"Overexpression and CHOP-KO osteoblast differentiation assays, heterodimerization and Runx2/DNA-binding inhibition, and EMSA/supershift in ST-2 cells\",\n      \"pmids\": [\"16880521\", \"14684614\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Opposing differentiation outcomes between systems not reconciled\", \"Role of BMP-2/Smad enhancement vs C/EBP inhibition unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Expanded DDIT3 dimer repertoire by showing JDP2 association redirects it to TRE elements and counteracts its proapoptotic activity.\",\n      \"evidence\": \"Co-IP, in vitro/in vivo DNA binding, reporter assays, and ER-stress viability assays\",\n      \"pmids\": [\"18463134\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous JDP2-DDIT3 target genes not identified\", \"Physiological balance of pro- vs anti-apoptotic dimers unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked DDIT3 and FUS-DDIT3 to cell-cycle machinery through CDK2 binding and altered cytoskeletal-protein affinity.\",\n      \"evidence\": \"Co-IP interaction screen among G1 cyclins/CDKs\",\n      \"pmids\": [\"20017906\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single Co-IP screen with limited functional follow-up\", \"Whether CDK2 binding mediates G1 arrest not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established DDIT3 as a direct regulator of microRNAs, inducing miR-708 (within Odz4) during ER stress to suppress rhodopsin.\",\n      \"evidence\": \"Genome-wide miRNA profiling with miR-708 gain/loss-of-function and rhodopsin target validation\",\n      \"pmids\": [\"21402790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DDIT3 binding at the miR-708 locus not mapped\", \"Broader miR-708 target network unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated that DDIT3 is a required effector of mutant-protein ER retention and chondrocyte death in pseudoachondroplasia.\",\n      \"evidence\": \"Genetic epistasis crossing D469del-COMP transgenic mice onto a Ddit3-null background\",\n      \"pmids\": [\"22154935\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking DDIT3 to mutant COMP retention not defined\", \"Transcriptional targets mediating chondrocyte death unidentified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Established that DDIT3 has compartment-specific functions, with cytoplasmic and nuclear pools regulating largely non-overlapping gene sets and distinct phenotypes (migration vs G1 arrest).\",\n      \"evidence\": \"Tamoxifen-inducible localization-targeted constructs with genome-wide expression, migration, and cell-cycle assays\",\n      \"pmids\": [\"22496745\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Partner identities in each compartment not defined\", \"How localization is regulated unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed post-transcriptional control of DDIT3 during adipogenesis, with RNase L destabilizing CHOP10 mRNA to permit terminal differentiation.\",\n      \"evidence\": \"RNase L-KO MEFs, mRNA association, ectopic RNase L rescue, siRNA epistasis, and aged-KO mouse phenotyping\",\n      \"pmids\": [\"22441668\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct RNase L cleavage site on CHOP10 mRNA not mapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined the principal degradation pathway for DDIT3, identifying it as a SPOP-CUL3-RBX1 substrate via a Ser/Thr-rich degron, with disease-mutant SPOP defective in its turnover.\",\n      \"evidence\": \"Ubiquitination assays, proteasome inhibition, degron mapping, and prostate-cancer SPOP mutant analysis\",\n      \"pmids\": [\"24990631\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals regulating SPOP recognition of DDIT3 not defined\", \"Cell contexts where this turnover dominates unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected DDIT3 to apoptotic amplification by showing PERK-dependent CHOP induces miR-216b to silence c-Jun and sensitize cells to ER-stress death.\",\n      \"evidence\": \"Loss-of-function at PERK, CHOP, and IRE1 nodes with miR-216b gain/loss and c-Jun target validation\",\n      \"pmids\": [\"27173017\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DDIT3 binding at the miR-216b promoter not mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined a transcription-factor cooperation mechanism in which DDIT3 partners phospho-c-Jun at the PUMA AP-1 site to drive lipotoxic apoptosis.\",\n      \"evidence\": \"Co-IP, ChIP at the PUMA AP-1 site, and CHOP shRNA with PUMA/Bax readouts in hepatocyte-relevant models\",\n      \"pmids\": [\"20430872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional DDIT3 binding site in the PUMA promoter found; reliance on AP-1 cooperation only\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Distinguished DDIT3-dependent death pathways in vivo, showing DDIT3 and JUN act independently and additively in retinal ganglion cell soma but neither prevents axonal degeneration.\",\n      \"evidence\": \"Single and double Jun/Ddit3 knockout mice in optic nerve crush with survival and electrophysiology readouts\",\n      \"pmids\": [\"28969695\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Independent DDIT3 effector genes in RGCs not defined\", \"Why axonal degeneration is unaffected unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mapped an oncogenic signaling output of the fusion protein, with FUS-DDIT3 inducing IGF2 to activate IGF-IR/PI3K/Akt in myxoid liposarcoma.\",\n      \"evidence\": \"FUS-DDIT3 overexpression/RNAi with IGF2 and pathway readouts and IGF-IR inhibition in vitro and in a CAM model\",\n      \"pmids\": [\"28637688\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect IGF2 transcriptional control not resolved\", \"Single-lab validation\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placed DDIT3 downstream of HMOX1-induced ER stress as a required effector of photoreceptor degeneration.\",\n      \"evidence\": \"AAV-HMOX1 overexpression in Ddit3-KO mice with RNA-seq, TUNEL, ERG, and immunostaining\",\n      \"pmids\": [\"33691741\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DDIT3 death-effector targets in photoreceptors not identified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Reframed DDIT3 in the mitochondrial ISR as an attenuator rather than activator, interacting with C/EBPβ to constrain ATF4 and prevent chronic ISR-driven energy crisis.\",\n      \"evidence\": \"Transgenic mitochondrial cardiomyopathy mice with CHOP-C/EBPβ interaction studies, ATF4/translation profiling, and cardiac/metabolic readouts\",\n      \"pmids\": [\"34039602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of how the heterodimer limits ATF4 not fully defined\", \"Generality beyond mitochondrial stress unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established DDIT3 as a dual-compartment metabolic regulator during glutamine deprivation, suppressing TIGAR in the nucleus to drive glycolysis and acting via a mitochondrial pool/LONP1 to suppress OXPHOS and ROS.\",\n      \"evidence\": \"Glutamine-deprivation induction, subcellular fractionation, LONP1 interaction, COQ9/COX4 regulation, and metabolic flux analysis\",\n      \"pmids\": [\"34105294\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of DDIT3 mitochondrial import not defined\", \"Direct vs indirect TIGAR regulation unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended DDIT3 to innate immunity, defining a DDIT3-OTUD1-Smurf1-MAVS axis that degrades MAVS and suppresses type I interferon.\",\n      \"evidence\": \"Overexpression/knockdown, NF-κB analysis, deubiquitination and ubiquitination assays, and Ddit3-KO mice with viral infection\",\n      \"pmids\": [\"33361422\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Primarily bovine MDBK cells with partial mouse validation\", \"Direct transcriptional control of OTUD1 not fully mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined a physiological β-cell role for DDIT3 in ER Ca2+ buffering and insulin secretion, with therapeutic targeting by a GLP1-conjugated antisense oligonucleotide.\",\n      \"evidence\": \"β-cell-specific Chop-KO mice on HFD with islet Ca2+ flux, chaperone profiling, hepatic lipid measurement, and GLP1-ASO treatment\",\n      \"pmids\": [\"34321322\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional targets governing ER chaperone remodeling not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified a direct transcriptional output linking DDIT3 to autophagy via SIRT1 promoter binding and the SIRT1-AKT pathway in chondrocytes.\",\n      \"evidence\": \"ChIP for SIRT1 promoter binding, overexpression/knockdown, Ddit3-KO mice, and autophagic-flux/SIRT1-modulator epistasis\",\n      \"pmids\": [\"34087318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dimer partner at the SIRT1 promoter not identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolved the chromatin mechanism of the fusion oncoprotein, showing FUS-DDIT3 sequesters CEBPB and inhibits BAF complex remodeling at adipogenic enhancers, mimicking SMARCB1-deficient tumors.\",\n      \"evidence\": \"Co-IP, ChIP-seq, ATAC-seq, transcriptomics, BAF ATPase inhibition, and FUS-DDIT3 knockdown\",\n      \"pmids\": [\"35390276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether wild-type DDIT3 similarly affects BAF not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connected DDIT3 to TXNIP-driven mitochondrial injury, showing DDIT3 upregulation promotes TXNIP mitochondrial shuttling to drive ROS, NLRP3 inflammasome, and ASK1-dependent apoptosis in nephrotic syndrome.\",\n      \"evidence\": \"Chop-/- and Txnip-/- mice, TXNIP subcellular fractionation, mitochondrial ROS imaging, and NLRP3/ASK1 assays\",\n      \"pmids\": [\"35994650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DDIT3 promotes TXNIP translocation mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined a stabilizing post-translational control by TXNIP, which binds the DDIT3 α-helix to reduce its ubiquitination and elevate protein levels in NASH.\",\n      \"evidence\": \"Co-IP domain mapping, ubiquitination assays, and Txnip knockdown in NASH mouse livers\",\n      \"pmids\": [\"37153733\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship between TXNIP stabilization and SPOP-mediated turnover not integrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DDIT3 selects among its many dimer partners and subcellular pools to choose between cytoprotective attenuation, differentiation block, and apoptosis in a given stress context remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model of partner/compartment selection\", \"Genome-wide direct DDIT3 binding landscape across stresses incomplete\", \"Quantitative interplay of p38 phosphorylation, SPOP degradation, and TXNIP stabilization in setting DDIT3 levels undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2, 8, 11, 13, 19, 34]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 8, 32, 34]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 6, 8, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 19]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10, 19]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [4, 22, 24, 30, 35]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [5, 16, 36]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 8, 13, 31, 34]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 11, 13]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 28, 40]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [21, 29]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [25]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"complexes\": [\n      \"FUS-DDIT3 fusion oncoprotein\",\n      \"EWS-DDIT3 fusion oncoprotein\"\n    ],\n    \"partners\": [\n      \"CEBPB\",\n      \"CEBPA\",\n      \"ATF3\",\n      \"JUN\",\n      \"JDP2\",\n      \"TXNIP\",\n      \"SPOP\",\n      \"CDK2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}